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During normal development as well as in diseased states such as cancer,
extracellular “niches” often provide cues to proximal cells and activate intracellular
pathways. Activation of such signaling pathways in turn instructs cellular
proliferation and differentiation. In the C.elegans gonad, GLP-1/Notch signaling
instructs germ line stem cells to self renew through mitotic cell division. As germ
cells progressively move out of the niche, they differentiate by entering meiosis and
eventually form gametes. Using this model system, I uncovered a cooperative role
for the METT-10 putative methyltransferase and the dynein motor complex in
regulating the balance between germ cell proliferation and differentiation. I
demonstrate that Dynein Light Chain-1 (DLC-1), and its partner, Dynein Heavy
Chain-1, inhibit the proliferative cell fate, in part through regulation of METT-10
levels and nuclear accumulation. I further show that the methyltransferase domain of
METT-10 is required for normal inhibition of germ cell proliferation, and that DLC-1
ii

and METT-10 act antagonistically to activation of the GLP-1 Notch pathway, which
plays conserved roles in stem cell fate specification. Moreover, I find that regulation
of germ cell proliferative fate is only one of multiple joint functions of METT-10 and
the dynein motor complex, and propose that they function together in multiple
cellular contexts, including mitotic cell division. The finding that METT-10 and
dynein inhibit germ cell proliferative fate, despite promoting mitotic cell division of
those cells that do proliferate, highlights a genetic difference between the
specification of proliferative fate and its execution.
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Chapter 1 (Introduction):
The C.elegans Germ Line as a Model for Stem Cell Biology
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A recurring theme of development and disease is the proper specification of
cell fates or lack thereof. Of the many developmental decisions that fall under the
umbrella of cell fate specification, the regulated balance between cell proliferation
and differentiation plays a fundamental role in tissue development and maintenance.
A specialized cell type, the stem cell, is the cornerstone of regulated proliferation and
differentiation, for it has the unique ability to both self-renew through proliferation
and to give rise to daughter cells that differentiate (Lin, 1997; Morrison et al., 1997).
While it is these fundamental characteristics that make stem cells alike, the genetics
and cell biology of stem cell fate and proliferation can differ according to organism,
tissue, and developmental context. A comprehensive understanding of the diversity
of paradigms regulating stem cell fate, maintenance, and proliferation will enhance
our fundamental views of what “stemness” entails, and its misregulation in disease
states such as cancer.

Current and contrasting models of stem cell self-renewal
Most models of stem cell self-renewal fall into three predominant paradigms:
(1) asymmetric division, wherein one daughter cell is specified to remain a stem cell
and the other daughter cell differentiates, (2) symmetric division in which the stem
cell divides to give rise to two daughter stem cells or two daughter cells that will
differentiate, and (3) population-level self-renewal wherein the collective behavior of
cells provides a steady source of proliferating cells that can differentiate at some
frequency (Lin, 1997). These paradigms are not organism-specific or tissue-specific,
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as multiple paradigms can operate within a single organism and in the same tissuetype between organisms.
Two excellent examples of the asymmetric division paradigm come from
studies in Drosophila, although this paradigm is also characterized in mammalian
tissues, including neural and hematopoietic stem cells (Takano et al., 2004;
Beckmann et al., 2007; Doe, 2008). Asymmetric division, which leads to the
formation of one stem cell and a daughter cell which differentiates, can be mediated
by intrinsic and extrinsic factors (Figure 1).
An example of the role of intrinsic factors in guiding asymmetric division
comes from studies of the Drosophila neuroblast (NB), which divides asymmetrically
to self-renew a NB and give rise to a Ganglion Mother Cell (GMC) that differentiates
(reviewed in (Doe, 2008). Proteins that are asymmetrically segregated between the
future NB and GMC play a significant role in determining cell fates. One example of
such a protein is the pro-differentiation factor Numb. Numb is segregated into the
future GMC and functions as an inhibitor of Notch signaling which promotes the selfrenewal fate (Uemura et al., 1989; Guo et al., 1996; Lu et al., 1998; Ohshiro et al.,
2000). Factors that are segregated into the future NB include aPKC, which among
other things, functions to inhibit proper localization of Numb (Smith et al., 2007).
Extrinsic factors guiding stem cell self-renewal are often provided by the
niche micro-environment (Walker et al., 2009). While such extrinsic factors are
probably essential for the establishment and/or maintenance of all stem cells, the
division of germ line stem cells (GSCs) in Drosophila provides a particularly elegant
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example of how extrinsic factors can determine stem cell fate. In the male, GSCs
reside at the apical tip of the testes surrounding a somatic hub, and divide to selfrenew a GSC and to give rise to a gonialblast that will differentiate (Dansereau and
Lasko, 2008). To remain a GSC, a cell must remain in contact with the hub, which
secretes the short range signaling molecule and JAK/STAT ligand Unpaired (Upd)
(Yamashita et al., 2003; Dansereau and Lasko, 2008). Activation of the JAK/STAT
signaling pathway maintains GSC fate. Because contact with the hub (which serves
as the stem cell niche) is essential for maintenance of GSC fate, asymmetric division
is achieved by orienting the mitotic spindle at a right angle to the GSC contact with
the hub (Yamashita et al., 2003). After cell division, one cell maintains hub contact
and remains a GSC, while the other lacks hub contact and becomes a gonialblast.
In contrast to the strictly asymmetric division observed for male Drosophila
GSCs, mammalian spermatogonial stem cells (SSCs) are proposed to undergo
symmetric cell division, although there is significant debate on this matter (Lin, 1997;
Oatley and Brinster, 2008). Under the symmetric model, SSCs exist in a niche that is
primarily made up of Sertoli cells (Oatley and Brinster, 2008). Undifferentiated type
A spermatogonia (As cells) act as stem cells, and can divide to give rise to either
additional two As cells that separate or to two Apr cells that remain as an
interconnected pair and differentiate (Lin, 1997).
The third paradigm, population-level self-renewal, is most clearly illustrated
by C. elegans germ cell development (Lin, 1997). The adult C. elegans
hermaphrodite gonad exists as two U-shaped gonad arms that meet at a common
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uterus (Figure 2). Each gonad functions as an assembly line with distal to proximal
polarity with respect to the uterus. At the distal region near the somatic distal tip cell
(DTC), extending approximately 18-20 cell diameters and encompassing 200-250
cells, are the proliferating germ cells, including the germ line stem cells (Hubbard,
2007). Proliferation of this distal cell population provides a continuous flux of germ
cells that pushes germ cells away from the distal niche and promotes their entry into
meiosis. At a staggered region called the “transition zone” corresponding to
leptotene/zygotene of meiosis I, germ cells definitively enter meiosis as evidenced by
expression of meiotic markers (Hansen et al., 2004a). These germ cells then proceed
through the stages of meiotic development to give rise to differentiated gametes or die
by physiological apoptosis (Hubbard, 2007; Jaramillo-Lambert et al., 2007).
Hermaphrodites first produce sperm at the 4th larval stage, and then switch to oocyte
production in the adult, and a continuously mated hermaphrodite can lay as many as
~1400 progeny in a lifetime (Kimble and Ward, 1988).
On the gross morphological level, the renewal of C. elegans germ line stem
cells resembles the renewal of male Drosophila GSCs, wherein the DTC takes the
place of the Drosophila hub. Similarly to the Drosophila hub, the DTC functions as a
stem cell niche. In fact, the DTC is necessary and sufficient for germ line
proliferation and maintenance: ectopic DTCs lead to additional proliferative zones
(and ectopic germ lines) while early distal tip cell ablation leads to germ line loss
(Kimble and White, 1981; Feng et al., 1999). The DTC functions as a stem cell niche
by expressing the membrane-bound Notch ligand LAG-2 and extends out cytoplasmic
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processes that enable it to directly contact cells located 8-10 cell diameters away from
the distal end (Kimble and Crittenden, 2007). Binding of LAG-2 to the GLP-1/Notch
receptor in the distal-most germ cells results in activation of the GLP-1/Notch
signaling pathway in the germ cells and specification of proliferative fate. Loss-offunction mutations in the GLP-1 receptor cause premature meiotic entry of all germ
cells, while GLP-1 hyperactivation causes germ cell overproliferation and germ line
tumor formation (Austin and Kimble, 1987; Berry et al., 1997; Pepper et al., 2003).
While C. elegans germ line development may resemble Drosophila GSC selfrenewal on the gross morphological level, there are significant differences. First,
there is no consistent spindle orientation among mitotically dividing C.elegans germ
cells, and thus there is no evidence for regulated asymmetric division (Crittenden et
al., 2006). In addition, while the distal tip cell has processes that extend
approximately 8-9 diameters away from the distal end, the proliferative zone extends
anywhere from 19-26 cell diameters, suggesting that cells can proliferate in the
absence of direct contact with the niche cell (Hansen et al., 2004a; Crittenden et al.,
2006). Thus, it is thought that differentiation may be a consequence of a progressive
displacement away from the niche (Morrison and Kimble, 2006), and the signaling
pathways that enable such a transition are the object of intense research, including the
thesis work presented here.
On the surface, there are significant differences among the paradigms of stem
cell self-renewal. However, whether similar underlying mechanisms operate to
ensure balanced stem cell self-renewal remains an open question. Like many
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biological examples, from developmental patterning to genome regulation, common
molecular strategies can underlie seemingly disparate outcomes; often, such examples
teach us what is most fundamental to the execution of a particular biological process.
The apparent uniqueness of the C. elegans strategy for germ line maintenance thus
makes it a prime candidate for expanding our understanding of stem cell self-renewal
and the pathways that limit it.

Genetic pathways underlying stem cell self-renewal and cancer
A genetic network ensures the switch from proliferative to meiotic fates in the
C. elegans germ line (Figure 2; Hansen and Schedl, 2006; Kimble and Crittenden,
2007). As stated earlier, the primary signal instructing germ cells to proliferate is
activation of the GLP-1/Notch signaling pathway in the germ cells themselves
through interaction with the somatic distal tip cell expressing the Notch ligand, LAG2. Binding of LAG-2 to GLP-1 receptor results in a series of cleavage events that
release the intracellular portion of GLP-1. GLP-1(INTRA) translocates to the nucleus
where it complexes with LAG-3, and acts as a co-activator for the LAG-1
transcription factor to promote the transcription of target genes that promote the
proliferative fate (reviewed in Fiuza and Arias, 2007). Most of these target genes
remain unknown, although there is evidence that the PUF protein, FBF-2, is a
transcriptional target of LAG-1 and functions to promote germ line stem cell
proliferation and/or maintenance (Lamont et al., 2004).
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There are two Notch receptors in the worm, lin-12 and glp-1. Although the
proteins are functionally equivalent, lin-12 function is limited to the soma and
embryo, and is best characterized in the vulva, while glp-1 functions in the germ line
and embryo (Fitzgerald et al., 1993). Germ line proliferation is roughly proportional
to the extent of GLP-1/Notch signaling. Weak glp-1 gain-of-function mutations
result in less penetrant and smaller tumors, while partial losses of glp-1 function
result in smaller germ lines (P.M. Fox, unpublished data; Qiao et al., 1995; Kerins,
2006). Moreover, the finding that cells continue to proliferate for at least 10 cell
diameters beyond the reaches of the distal tip cell means that Notch signaling persists
outside of the DTC niche and is dampened with relatively standardized timing. Thus,
regulation of the strength and endurance of the glp-1 signal ensures a proper balance
between germ line proliferation and differentiation. In many systems, the Notch
molecule is regulated at the level of expression, surface availability, intracellular
trafficking, and stability (Fortini, 2009; Fortini and Bilder, 2009). In the C.elegans
germ line specifically, several proteins have been propose to regulate Notch activity.
These include a number of the sel (suppressor enhancer of lin-12) genes, most
notably, sel-10, an E3-ubiquitin ligase that regulates Notch levels (Sundaram and
Greenwald, 1993; Lai, 2002) and the proteasomal component, pas-5 (Macdonald et
al., 2008).
GLP-1 signaling inhibits at least three genetic pathways that promote meiotic
entry and/or inhibit proliferation (Figure 2; Hansen et al., 2004a). Two of these
pathways are characterized by the genes gld-1 and gld-2; gld-1 encodes a K-
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homology RNA binding domain containing protein and functions as a translational
repressor, while gld-2 encodes a poly-A polymerase and functions, in part, to promote
GLD-1 levels (Jones and Schedl, 1995; Lee and Schedl, 2001; Wang et al., 2002;
Hansen et al., 2004b). gld-1 and gld-2 single mutants exhibit a significant amount of
meiotic entry and various meiotic defects (Francis et al., 1995; Kadyk and Kimble,
1998). However, simultaneous disruption of gld-1 and gld-2 leads to the formation of
large germ line tumors with minimal meiotic entry (Kadyk and Kimble, 1998; Hansen
et al., 2004a). Moreover, these tumors occur in the absence of glp-1 activity,
demonstrating that one of the primary roles of glp-1 signaling is to inhibit the
function of gld-1 and gld-2. The fact that some meiotic entry is observed in gld-1 gld2 double mutants demonstrates that at least one other pathway operates in parallel to
gld-1 and gld-2 to promote meiotic entry (Hansen et al., 2004a). Several other genes,
namely gld-3 and the PUF protein nos-3, also promote meiotic entry and inhibit
proliferation downstream of glp-1. These proteins, like gld-2, function in part to
promote GLD-1 levels (Eckmann et al., 2004; Hansen et al., 2004b). GLD-1, in turn,
represses translation of a number of target genes, including glp-1 itself (Marin and
Evans, 2003).
One of the key questions in stem cell biology is whether similar genetic
mechanisms underlie the diversity of paradigms for stem cell self-renewal. Several
lines of evidence suggest that homologous factors regulate stem cell fate and
proliferation across paradigms. These factors include the PUF (Pumilio and FBF)
protein family of translational regulators, piwi proteins, and the Notch signaling
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pathway (Wong et al., 2005). The Notch signaling pathway plays a particularly
pervasive role in stem cell regulation. In addition to promoting C. elegans germ cell
proliferative fate, Notch signaling promotes the adoption of the NB stem cell fate in
Drosophila (Doe, 2008) and the maintenance of stem cell fate in several mammalian
cell and tissue types, including melanoblasts, neuroblasts, hematopoietic precursors,
and the intestine (Pinnix and Herlyn, 2007; Doe, 2008). In most cases, Notch is
activated in the stem cell itself, but the stem cell can also act as the ligand expressing
signaling cell in order to promote its own maintenance. For example, female
Drosophila germ line stem cells express the Notch ligands Delta and Serrate and
signal to the niche. One function of the signal is to maintain the population of niche
cells, which in turn, maintains germ line stem cell fate (Dansereau and Lasko, 2008).
Notch plays two qualitatively different roles in promoting stem cell
proliferation. Notch signaling specifies stem cell fate and promotes proliferation per
se through regulation of cell cycle progression mechanisms. Both these roles can be
co-opted by a number of cancers. One example of the role of Notch activation in
cancer is the inception and growth of T-acute lymphoblastic leukemia (T-ALL) (Roy
et al., 2007). Activating mutations in Notch1 are found in 55-60% of all cases of TALL. Notch likely promotes T-cell proliferation through upregulation of c-myc and
downregulation of p53. In addition, Notch1 plays early roles in T-cell development
and fate specification, and it is thought that its leukemiogenic activity is a distortion
of its regular developmental functions.
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On a broader scale, increasing evidence suggests that Notch activation may
promote cancer through inappropriate specification of stem cell fate. The “cancer
stem cell hypothesis” proposes that many tumors are comprised of heterogenous
population of cells that includes “cancer stem cells” – that is, cells that have the
ability to self-renew and give rise to other cell types within the tumor (Visvader and
Lindeman, 2008). It is thought that cancer stem cells play key roles in tumor
initiation, metastasis, and significantly, resistance to conventional treatments
targeting only rapidly amplifying cell populations. In some breast and brain cancers,
it is proposed that aberrant Notch signaling promotes the self-renewal fate of cancer
stem cells (Farnie and Clarke, 2007; Garzia et al., 2009; Korkaya and Wicha, 2009).
Whether Notch activation affects cell fate or cell proliferation in a particular cancer is
likely to be an important clinical consideration.
Finally, there are several situations where Notch acts to inhibit stem cell
proliferation and self-renewal. For example, in mammalian skin, Notch1 acts as a
tumor suppressor, as deletions lead to basal cell carcinoma (Roy et al., 2007), and
Notch inhibits stem cell fate in the Drosophila midgut (Micchelli and Perrimon,
2006).

Stem cell self-renewal and cell proliferation
Stem cell proliferation and self-renewal are separable though interrelated
processes. The term “proliferation” refers to cell division, while “self-renewal” refers
to the specification of stem cell fate. In the asymmetric paradigm, where each division
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leads to the renewal of the stem cell and an addition of a cell that will differentiate,
cell division is separable from cell fate specification, and there are genetic factors that
have been shown to specifically affect one process or the other (Doe, 2008). This is
also true for symmetric cell division, where daughter cells must choose between
“stem cell” and “differentiated” cell fates.
The difference between proliferation and self-renewal is less clear when
considering the paradigm of population level self-renewal in the C. elegans germ line,
in part because what distinguishes the “stem-cell like” from “differentiated” cell
populations is their method of cell division. The distal proliferative zone is often
referred to as the “mitotic zone” and the process of differentiation as the
“mitosis/meiosis switch” (Kimble and Crittenden, 2007). Thus, the relationship
between cell fate and cell division in the C. elegans germ line remains a relatively
open question.
One unanswered question is whether failures in one type of cell division or the
other result in a fate change, or whether cell fates are specified prior to and
independently of the ability of cells to execute mitosis or meiosis. Some mutations
(in the RNA regulators gld-1 and puf-8) that prevent the normal meiotic progression
cause a return to mitosis (Francis et al., 1995; Subramaniam and Seydoux, 2003),
suggesting that a failure in meiotic progression can lead to a reversal in cell fate,
although it is unclear whether ectopically proliferating cells share the stem cell
character of the distal population. However, there are numerous mutations that
disrupt meiosis, including early meiotic steps, that do not cause a return to mitosis,
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suggesting that only specific progression defects can reverse cell fate (MacQueen and
Villeneuve, 2001; MacQueen et al., 2002; Martinez-Perez and Villeneuve, 2005; Lee
et al., 2007; Goodyer et al., 2008). Furthermore, some genetic perturbations that
cause mitotic cell cycle arrest do not cause bulk meiotic entry. These include germ
line RNAi of the Cdk1 homolog, ncc-1 (S. Arur, unpublished data) and mutations in
glp-4 (Beanan and Strome, 1992). However, it is possible that these factors are also
required for meiosis as well. Moreover, it is unknown if C.elegans germ cells can
enter meiosis only at particular cell cycle stage, and how cell cycle progression may
bear on competence for meiotic entry (Hubbard, 2007).
Because the term “proliferation” has been used to refer to both cell division
and fate choice in the C.elegans germ line, perhaps it is most appropriate to define
“proliferative fate” as a decision to mitotically divide, and “proliferation per se” as
the act of mitotic division. Indeed, one of the main contributions of the thesis work
presented here is to demonstrate that two factors required for a normal mitotic cell
cycle, METT-10 and dynein, inhibit the specification of germ cell proliferative fate,
demonstrating that proliferative fate is genetically separable from the act of mitotic
cell division itself.
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Figure 1. Models of Asymmetric and Symmetric Stem Cell Division. Cells that
will adopt the “stem cell fate” are shown in green, cells that will differentiate are
shown in red. (A-B) Asymmetric division of stem cells is mediated by intrinsic and
extrinsic factors. (A) In the Drosophila NB, the asymmetric localization of cell fate
determinants relative to spindle orientation is essential for the adoption of differential
cell fates. (B) Male germ line stem cells maintain their “stem cell fate” through
contact with the somatic cell hub, which expresses the short-range signaling molecule
Unpaired. Asymmetric division is achieved by orienting the mitotic spindle
perpendicular to cell contact with the hub, ensuring that only one cell maintains hub
contact. (C) It is thought that mammalian male germ line stem cells undergo either
symmetric division to either expand the stem cell population or to give rise to two
(connected) cells that will differentiate.
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Figure 2. Physical and genetic architecture of the proliferation versus meiotic
entry decision in the C. elegans germ line. The C.elegans adult hermaphrodite has
two U-shaped gonad arms that meet at a common uterus. Each arm is organized with
a distal to proximal polarity. At the distal region of the germ line, in contact with the
somatic distal tip cell (1), are the proliferating germ cells (2). Proliferation of these
cells results in a net flux of germ cells away from the niche provided by the DTC, and
meiotic entry at a region called the transition zone (3). Germ cells that proceed
through an extended meiotic prophase (4) to eventual give rise to sperm (5) at the L4
larval stage and oocytes (6) in adulthood. (A) Binding of the LAG-2 ligand
(expressed by the DTC) to the GLP-1 Notch receptor in the distal-most germ cells
activates the GLP-1/Notch signaling pathway and promotes the proliferative or stem
cell fate. One function of the GLP-1 signaling pathway is to repress the activity of
genetic pathways that promote entry into meiosis and inhibits the proliferative fate
(B).
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Chapter 2:
METT-10, A Putative Methyltransferase, Inhibits Germ Cell Proliferative Fate
in Caenorhabditis elegans
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INTRODUCTION
From early development to later life, tissues are formed and maintained by
stem cell populations. Stem cells have the unique ability to give rise to both
differentiated cell types and self-renewing daughters, and must decide between
maintaining self-renewing capability and differentiating. A balance between cell
proliferation and differentiation is critical for normal tissue development and the
avoidance of disease. For instance, uncontrolled self-renewal is a hallmark of cancer
(Krivtsov et al., 2006), while a failure to maintain proliferation is often equally
detrimental (Kauffman et al., 2003).
The Caenorhabditis elegans germline offers an excellent model system to
study factors regulating this balance. C. elegans germ cells begin from germline
precursors set aside early in life (Sulston et al., 1983). Following initiation of postembryonic development, germline stem cells are specified to maintain a proliferative
fate and undergo mitotic cell division, or to differentiate into gametes, whereby they
enter a meiotic developmental program (Hansen and Schedl, 2006; Kimble and
Crittenden, 2007). This decision is spatially regulated within the gonad. Proliferating
germ cells reside in the distal end and enter meiosis more proximally at a region of
the germline called the "transition zone", which corresponds to leptotene/zygotene of
meiosis I (Figure 1A). Currently, there is no evidence for asymmetric division within
the proliferative zone, and it is thought that differentiation may be the consequence of
progressive displacement away from the niche (Morrison and Kimble, 2006).
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The signal for continued proliferation of germ cell precursors is provided by
activation of the Notch signaling pathway in distal germ cells (Austin and Kimble,
1987; Berry et al., 1997). The ligand LAG-2, a member of the conserved family of
Delta/Serrate proteins, is expressed by a somatic cell called the distal tip cell,
effectively creating a "niche” (Henderson et al., 1994). Binding of LAG-2 to GLP-1
(one of two C. elegans Notch receptors) likely results in cleavage of the intracellular
domain of GLP-1 and its subsequent translocation to the nucleus (Mumm and Kopan,
2000). Upon translocation to the nucleus, GLP-1 (INTRA) complexes with other
proteins, such as the DNA-binding transcription factor LAG-1, to activate
transcription of target genes which promote the proliferative fate (Lamont et al.,
2004; Wilson and Kovall, 2006). This role of GLP-1 in promoting the choice of
proliferative fate was elucidated primarily by genetic analysis. Loss of glp-1 function
results in the premature differentiation and meiotic entry of all germ cells (Austin and
Kimble, 1987), while constitutive activation of glp-1 causes germline tumors (Berry
et al., 1997).
Although glp-1 signaling is a central component controlling the specification
of germ cell proliferative fate, the mechanism of this important cellular decision is far
from understood. A complete picture of the components that transduce or inhibit the
glp-1 signal, govern the maintenance of proliferative cells, and ensure their proper
differentiation and entry into meiosis is essential for understanding cell fate decisions
including aberrant cell fate decisions leading to human cancers (Weng et al., 2004;
Koch and Radtke, 2007).
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To further characterize the specification of germ cell proliferative fate, we
characterized a novel tumorous allele of the mett-10 gene isolated in a forward
genetic screen for factors that disrupt the balance between germ cell proliferation and
differentiation (Francis et al., 1995a). We demonstrate that METT-10, a conserved
putative methyltransferase, inhibits germ cell proliferative fate in C. elegans, possibly
through inhibition of the pro-proliferative functions of the glp-1/Notch signaling
pathway.

RESULTS
A mett-10 allele with a tumorous phenotype
To identify genes regulating the transition between proliferative and meiotic
fates, we carried out a screen for recessive tumorous mutants exhibiting ectopic or
excessive proliferation (Francis et al., 1995a). We isolated an allele of mett-10, the
worm ortholog of the METT10D putative methyltransferase of vertebrates (see
below); mett-10(oz36) exhibits a cold-sensitive and partially penetrant tumorous
phenotype (Table 1). The tumorous phenotype is variable and includes both regions
of ectopic proliferation near the “loop” region of the germline normally occupied by
cells in meiotic pachytene, as well as what is typically called the “late-onset
tumorous” phenotype, in which the distal proliferative zone progressively increases in
length as the animals age. These phenotypes indicate an imbalance of proliferation
over differentiation similar to glp-1/Notch gain-of-function mutations (Berry et al.,
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1997; Pepper et al., 2003), and are distinct from tumors that arise from a return to
proliferation from meiotic development (Francis et al., 1995a; Subramaniam and
Seydoux, 2003) or that result from disrupting the function of multiple factors acting
downstream of glp-1 to promote meiotic entry (Kadyk and Kimble, 1998; Eckmann et
al., 2004; Hansen et al., 2004a).
We confirmed that the cells suspected to be ectopic proliferating cells are
cycling by testing for incorporation of the nucleotide analog, EdU, which labels cells
in S-phase of the cell cycle (Salic and Mitchison, 2008). In wild type germlines, a 3
hour pulse of EdU labels most cells in the proliferative zone, but not in the adjacent
meiotic region (Figure 1B). The suspected ectopic proliferating cells in the mett10(oz36) mutant label with EdU within a 3 hour period, demonstrating that they are
cycling (Figure 1C). Because EdU labels cells both in mitotic as well as meiotic Sphase, we further characterized these cells by staining for additional mitotic and
meiotic markers. Ectopic phospho-histone-3 (pH3) nuclei were observed in mett10(oz36) mutants, consistent with ectopic mitosis (Figure 1D-E). Furthermore, these
cells were negative for the meiotic marker, GLD-1 (Hansen et al., 2004b). Together,
these data suggest that the mett-10(oz36) mutation causes the proliferation of germ
cells which should otherwise have entered meiosis. Because the C.elegans germline
stem cells have not been unequivocally identified, we cannot definitively attribute our
phenotype to overproliferation of the germline stem cells themselves, rather than a
potential transient amplifying population. However, the degree of tumor formation
seen in older animals, coupled with the similarity of the overproliferative phenotype
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to that of glp-1/Notch gain-of-function mutants suggests that mett-10(oz36) may
affect stem cell fate specification.
We cloned mett-10 by genetic mapping, cosmid rescue, and sequencing of
candidate genes. Several lines of evidence indicate that the gene affected by the oz36
mutation is ZK1128.2, the ortholog of human Methyltransferase-10 Domain
Containing protein (METT10D) (Figure 2A). First, the mutation responsible for the
tumorous phenotype genetically maps to a genomic region containing ZK1128.2 (data
not shown). Second, a transgene containing the ZK1128.2 coding region rescues the
mett-10(oz36) mutant phenotype (Table 1). Finally, sequencing of the oz36 allele, as
well as other mutations in the same complementation group (see below), all reveal
molecular lesions within the ZK1128.2 coding region (Figure 2B).
The N-terminal domain of human METT10D was crystallized in complex
with S-adenosyl methionine (SAM), the substrate used by SAM-dependent
methyltransferases to catalyze the transfer of a methyl group to a wide variety of
substrates, including protein, DNA, RNA, small molecules and lipids (Martin and
McMillan, 2002; Wu et al., To be published.). Based on sequence conservation and
secondary structure prediction, C.elegans METT-10 is predicted to bind SAM (Figure
2A). Furthermore, both human and C.elegans METT-10 contain a full “SAMdependent methyltransferase fold”, including conserved protein motifs known to be
responsible for the catalysis of the methyl-transfer (Figure 2A; Malone et al., 1995).
With only two known exceptions, proteins containing the SAM-dependent
methyltransferase fold act as methyltransferases (see Discussion). Thus, it is highly
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likely that METT-10 acts as a methyltransferase in C. elegans, although the
biochemical nature of the substrate is unknown at this time.

Loss of mett-10 function results in multiple temperature-sensitive phenotypes
The oz36 mutation creates a premature stop codon that truncates the protein
shortly after the putative methyltransferase domain. While the mett-10(oz36) mutant
is tumorous at lower temperatures (Table 1), at 25˚C it behaves as a loss-of-function
and fails to complement a deficiency (nDf40). At this non-permissive temperature,
mett-10(oz36) animals are sterile (Ste) or maternal-effect lethal (Mel), with multiple
somatic phenotypes including slow growth (Gro), a protruding vulva (Pvl), and
distension of the intestinal lumen (data not shown, Table 2, Figure 3B,E).
We identified two additional mett-10 alleles by testing uncloned Ste/Pvl
mutants mapping to the same genetic region for complementation of mett-10(oz36) at
25˚C (Figure 2B). mett-10(g38) was first identified as let-42 in previous screens for
maternal effect lethal mutations (Cassada et al., 1981). mett-10(oj32) was isolated in
a screen for temperature sensitive sterile and uncoordinated mutants and was
originally named stu-18 (O'Connell et al., 1998). Based on sequence conservation
between C. elegans METT-10 and Human METT10D, the oj32 mutation (G110R)
disrupts a conserved glycine that binds to S-adenosyl methionine, the substrate used
by SAM-dependent methyltransferases, and thus should compromise enzymatic
activity (Figure 2, Malone et al., 1995).
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Two deletion alleles were obtained from the Japanese National Bioresource
Project (tm2697) and the C. elegans gene knockout consortium (ok2204) (Figure 2B).
The tm2697 deletion is an internal in-frame deletion C-terminal to the core of the
conserved methyltransferase domain. The ok2204 deletion removes the entire
methyltransferase domain, and we believe that it is essentially a null allele.
Like mett-10(oz36), all other mett-10 alleles exhibit a temperature sensitive
Ste/Mel/Pvl phenotype (Table 2, Figure 3C,F). Germline sterility in mett-10 loss-offunction mutants appears to be a result of abnormalities in gonad morphology and
defects in germ cell meiotic development. At 25˚C, 30% of mett-10(ok2204)
germlines have at least one extra protrusion in this distal gonad (Figure 4A-B).
Moreover, many germlines contain pachytene cells in the proximal-most region of the
germline, normally occupied by diakinetic oocytes (data not shown). In situations
where proximal mett-10(ok2204) germ cells progress from pachytene to diplotene,
there is often a disruption of normal linear oocyte organization (Figure 4E-F).
In addition to abnormalities in their meiotic development, and unlike mett10(oz36) germline tumors, mett-10(ok2204) germ cells appear to have difficulty in
progressing through the mitotic cell cycle. At all temperatures, the proliferative zone
of mett-10(ok2204) germlines contain abnormally large, diffuse nuclei (Figure 4B,D).
Because this nuclear morphology is associated with cell cycle arrest (Gartner et al.,
2000; Moser et al., 2009), we tested if these cells were actively cycling by labeling
with EdU and co-staining for phospho-histone-3. We found that these large cells do
not incorporate EdU during a time period sufficient to label essentially all
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proliferative zone nuclei in wild type germlines and are not pH3 –positive (Figure
4C-D). Together, these data suggest that these large nuclei arrest at some point other
than M-phase of the cycle, and thus, that METT-10 may normally promote mitotic
cell cycle progression. Overall, mett-10 loss-of-function germlines are quite small at
25˚C, suggesting that METT-10 may contribute to the execution of proliferation per
se.
In additional to the developmental defects described above, we observed that
mett-10 mutants exhibit defects in susceptibility to RNA interference (RNAi) at all
temperatures. To better characterize this phenotype, we tested multiple mett-10
alleles for their susceptibility to dsRNA directed against the somatic gene, unc-22,
and the germ line gene, gld-1. We found that mutations in mett-10 have strong
effects on germ line RNAi, but relatively mild effects on the soma (Figure 5),
suggesting that METT-10 normally functions to promote the RNA interference
pathway in the germ line. Significantly, mett-10 RNAi defects are not suppressed by
a mutation in eri-1, a nuclease that acts downstream to the “core” RNAi machinery to
degrade siRNAs generated by exogenous RNAi, suggesting that METT-10 may
function in the generation of functional siRNAs (Figure 5 and Kennedy et al., 2004).
Consistent with their loss-of-function nature, mett-10 somatic and germline
defects are suppressed by a wild-type mett-10 transgene (Table 2, data not shown)
and, with the exception of maternal effect embryonic lethality and RNAi-resistance,
mett-10 phenotypes are maternally rescued (Table 2). Significantly, while all alleles
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exhibit the Ste/Mel/Pvl phenotype with variable penetrance at 25˚C, in contrast to
mett-10(oz36), none are tumorous under any temperature condition (Table 3).

mett-10(oz36) likely produces a “poisonous” product
Since mett-10(oz36) is the only allele that is tumorous on its own, we thought
it possible that the mutation might confer a novel activity unrelated to the normal
mett-10(+) function. However, the evidence indicates that this is not the case. If
mett-10(oz36) is tumorous because it has acquired a new function, then the tumorous
phenotype should be unmodified by a wild type copy of mett-10. However, the
tumorous phenotype of mett-10 (oz36) is recessive and is also completely suppressed
by a wild type transgene (Table 1).
Genetic experiments indicate that mett-10(oz36) likely encodes a product that
poisons processes in which mett-10(+) normally participates. If mett-10(oz36)
encodes a poisonous product, the tumorous phenotype should depend on the dosage
of mett-10(oz36). To increase the effective dose of mett-10(oz36), we took advantage
of the fact that the oz36 mutation is a premature stop codon and that the transcript
should be degraded by nonsense-mediated decay (NMD). Disruption of NMD should
therefore result in increased production of a ‘poisonous product’ (Hodgkin et al.,
1989; Page et al., 1999). We observed that genetic disruption of NMD by the smg2(e2008) mutation significantly enhances the overproliferation phenotype of mett10(oz36) to 98% penetrance (Table 1). NMD-disruption also enhances the degree of
tumor formation in the mutants, with much larger tumors forming in smg-2(e2008);
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mett-10(oz36) animals than in mett-10(oz36) animals alone (Figure 6B-C).
Interestingly, even in an NMD-defective background, mett-10(oz36) is recessive,
indicating that wild type METT-10 fully suppresses the tumorous phenotype (Table
1). This suggests that the tumorous phenotype of mett-10(oz36) mutants may be
caused by the simultaneous loss of METT-10 function, and the poisoning of another
protein by METT-10(oz36). Supporting this idea, heteroallelic mett-10(oz36)/mett10(g38) mutants exhibit a partially penetrant tumorous phenotype that is more severe
than mett-10(oz36)/mett-10 (+) and less severe than mett-10(oz36) homozygotes in an
NMD-defective background (Table 1).
NMD-disruption also enhances maternal-effect embryonic lethality in the
mett-10(oz36) mutant, as the few progeny laid by smg-2(e2008); mett-10(oz36)
mothers at 15˚C or 20˚C die late in embryogenesis or shortly after hatching with a
variety of abnormalities (Figure 3G-I). This suggests that mett-10(oz36) expression
may also disrupt some aspect of embryonic development.

METT-10 inhibits germ cell proliferative fate
A straightforward interpretation of the mett-10(oz36) tumorous phenotype is
that wild type METT-10 inhibits specification of germ cell proliferative fate.
However, because the mett-10(oz36) allele forms a product that poisons other
processes, it was also possible that it may indirectly affect proliferative fate
specification. To address this possibility, we tested if mett-10 loss-of-function alleles
were also compromised for the proliferative/meiotic fate decision. Because none of
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these alleles are tumorous on their own, we tested their ability to enhance a genetic
background sensitized for the tumorous phenotype by an elevation of glp-1/Notch
activity [glp-1(oz264)](Kerins, 2006). We found that mett-10 alleles significantly
enhance the glp-1(oz264) tumorous phenotype at 20˚C (Table 3), demonstrating that
METT-10 normally either inhibits germ cell proliferative fate or promotes meiotic
entry.
Our conclusion that METT-10 normally acts to inhibit germ cell proliferation
and/or promote meiotic entry is further supported by our finding that mett-10 loss-offunction alleles can partially suppress the premature meiotic entry phenotype of a
temperature-sensitive glp-1 loss-of-function mutant [glp-1(bn18)] (Kodoyianni et al.,
1992; Qiao et al., 1995). Adult glp-1 (bn18) animals raised at 20˚C and shifted to
25˚C for six hours have minimal proliferative zones and an absence of nuclei in Mphase (as evidenced by an absence of phospho-histone-3 (pH3)-positive nuclei)
because removal of glp-1/Notch signaling induces all germ cells to enter meiosis
(Figure 7E,F,J; P. Fox and T. Schedl, unpublished data; Kodoyianni et al., 1992; Qiao
et al., 1995). However, we observed pH3-positive nuclei, albeit reduced in number,
in glp-1(bn18) mett-10(g38) double mutants after a six hour shift, despite equivalent
numbers of pH3-positive nuclei in glp-1(bn18) and glp-1(bn18) mett-10(g38)
unshifted controls (Figure 7G,H,J). The reduction in overall proliferative zone size
and number of pH3-positive nuclei in glp-1(bn18) mett-10(g38) germlines upon
temperature-shift suggests that germ cells are still induced to enter meiosis upon
removal of glp-1 signaling, although with different temporal dynamics; in support of
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this, longer shifts of glp-1(bn18) mett-10(g38) animals result in the meiotic entry of
all germ cells (Figure 7I).
Given the central role of glp-1/Notch signaling in the specification of germ
cell proliferative fate, we sought to determine if METT-10 normally acts downstream
of, upstream of, or in parallel to glp-1 to inhibit germ cell proliferative fate. Several
lines of evidence indicate that it is unlikely that GLP-1 normally acts to inhibit
METT-10. The first makes use of the fact that METT-10(oz36) acts similarly to a
dominant negative protein, in that increased expression of the mutant protein drives
the overproliferation phenotype towards the mett-10 loss-of-function direction. Thus,
if GLP-1 acts upstream of METT-10, we would not expect the mett-10(oz36)
tumorous phenotype to be dependent on glp-1 activity. However, we find that tumor
formation in the mett-10(oz36) background is exquisitely dependent on glp-1
signaling; glp-1(bn18) fully suppresses the smg-2(e2008); mett-10(oz36) tumorous
(but not the embryonic lethality) phenotype at the permissive temperature of 20˚C
(Table 1, Figure 6C-E), suggesting that METT-10 may negatively regulate glp-1
signaling to inhibit the specification of proliferative fate.
The idea that METT-10 acts upstream of or in parallel to glp-1 signaling to
inhibit germ cell proliferation is further supported by our analysis of genetic
interactions between mett-10 and the genetic pathways that function downstream of
glp-1 to redundantly promote meiotic entry. These pathways are defined by the genes
gld-1 and gld-2. In animals that have lost either gld-1 or gld-2, germ cells enter
meiosis, but do not undergo normal meiotic progression (Francis et al., 1995b; Kadyk
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and Kimble, 1998). Germ cells that have lost both gld-1 and gld-2 fail to enter
meiosis, resulting in germline tumors that are independent of glp-1 activity (Kadyk
and Kimble, 1998; Hansen et al., 2004a). We made double mutants between mett10(oz36) and null alleles of gld-1, gld-2, and gld-3 (which acts in the gld-2 pathway)
(Eckmann et al., 2004). Since gld-1(q485) hermaprodites have germline tumors that
are due to a return to mitosis, while males are unaffected (Francis et al., 1995a), we
analyzed gld-1(q485); mett-10(oz36) males and found that mett-10(oz36) does not act
redundantly with gld-1 to promote meiotic entry (Table 4). Furthermore, we found
that while gld-2(q497) enhanced the mett-10(oz36) tumorous phenotype, this was
completely suppressible by a reduction in glp-1 activity introduced either by the glp-1
null allele, glp-1(q175), or even the temperature-sensitive glp-1 hypomorph, glp1(bn18), raised at the permissive temperature of 20˚C (Figure 8, Table 4). Results
similar to those for gld-2 were observed for gld-3 (Table 4).

METT-10 is a nuclear protein expressed in many cell types
To localize the METT-10 protein in vivo, we expressed a GFP-tagged version
of METT-10 under control of the endogenous promoter (see Methods) as an
extrachromosomal array. We found that METT-10::GFP is a nuclear protein
expressed in many of the same tissues where mett-10 disruption causes phenotypic
abnormalities, including the intestine, vulva, and cells of the somatic gonad including
the distal tip cell, gonadal sheath cells, and spermatheca (Figure 9A-E).

39

To visualize METT-10 expression in the germline, where extrachromosomal
arrays are often silenced relative to somatic copies (although mett-10::gfp is weakly
expressed in the germline from an array), we generated an integrated version of
pmett-10:mett-10::gfp. METT-10::GFP expression rescues all mett-10 mutant
phenotypes (Tables 1-3). The observed germline localization of METT-10 is
consistent with its role in inhibition of germ cell proliferative fate; METT-10::GFP
protein levels are low in the distal proliferative zone and increase as cells enter
meiosis, although some proliferative nuclei are positive (Figure 10). METT-10::GFP
persists throughout meiotic prophase as a predominantly nuclear protein that does not
colocalize with DNA (Figures 9F & 11).
The germ line expression pattern of METT-10 is altered in both glp-1 loss-offunction and gain-of-function mutant backgrounds. In line with our previous
observation that METT-10 accumulates as germ cells enter meiosis, we find that in
shifted glp-1(bn18) animals in which almost all germ cells have entered meiosis,
nuclear METT-10 is uniformly detected in distally located meiotic nuclei (Figure 10).
However, there is also an increase in METT-10 in distal nuclei when we shift the glp1 gain-of-function mutant, glp-1(ar202), to 25˚C to induce tumor formation, although
patches expressing low METT-10 levels can be found (Figure 10). It is likely that
this represents an expansion of the normally small proliferative zone population that
expresses METT-10 and that may require its function for normal cell cycle
progression. Our finding that METT-10 expression does not inversely correlate with
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levels of GLP-1 activity further supports our hypothesis that METT-10 functions
upstream of or in parallel to GLP-1 to antagonize its pro-proliferative functions.

METT-10 acts in the germline to inhibit germ cell proliferative fate
Since METT-10 is expressed in both the germline and the soma, including
cells of the somatic gonad that can affect germ cell fate (McCarter et al., 1997;
Killian and Hubbard, 2004; Voutev et al., 2006), we used mosaic analysis to
determine whether METT-10 acts in the soma or the germline to inhibit germ cell
proliferative fate. We carried out mosaic analysis by taking advantage of the fact that
in C. elegans, injected DNA forms extrachromosomal arrays that are imperfectly
transmitted during cell division (Yochem and Herman, 2005). To form marked
extrachromosomal arrays carrying wild type mett-10, we co-injected a rescuing mett10 (+) construct with a construct carrying the sur-5::GFP cell autonomous marker
that is expressed in the nuclei of almost all somatic cells (Yochem et al., 1998). We
found that, even with loss in the somatic gonad, the presence of the sur-5::GFP; mett10(+) array in the germline (detected by transmission of the array to progeny) fully
suppresses the tumorous phenotype of the smg-2(e2008); mett-10(oz36) double
mutant (Figure 12). Conversely, expression of mett-10 (+) in cells of the somatic
gonad did not suppress the smg-2 (e2008); mett-10(oz36) tumorous phenotype in the
event of germline loss (Figure 12) . We conclude that METT-10 acts in the germline
to inhibit the specification of proliferative fate.
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DISCUSSION
Unlike the post-mitotic soma, the adult C. elegans germline is a dynamic
system; germ cells proliferate through mitotic cell division to maintain their
population, and at some frequency, switch to meiosis to produce gametes (Crittenden
et al., 2003; Hansen and Schedl, 2006; Kimble and Crittenden, 2007). The temporal
and spatial dynamics of this decision, as well as the conservation of the Notch
pathway that governs germ cell proliferation, makes it an excellent system to study
the genetic architecture governing stem cell proliferation and fate specification. Here
we identify a role for the previously uncharacterized, though highly conserved,
METT-10 putative methyltransferase in inhibiting the choice of proliferative fate in
the C. elegans germline. In addition to its role in proliferative fate specification, we
find that METT-10 is essential for normal germ line RNAi sensitivity, development
of the vulva, somatic gonad, and embryo, and contributes to the progression of germ
cells through both mitosis and meiosis. The role of METT-10 in promoting mitotic
cell cycle progression, while inhibiting the specification of proliferative fate,
delineates a genetic difference between the developmental decision of proliferate fate
specification and the process of cell proliferation per se.

METT-10 acts as an inhibitor of germ cell proliferative fate in C. elegans
Likely by way of stem cell fate specification, germ cell proliferation is
promoted by the conserved glp-1/Notch signaling pathway (Crittenden et al., 2003;
Hansen and Schedl, 2006; Kimble and Crittenden, 2007). One approach to identify
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regulators of the germ cell proliferation is to study mutations that phenocopy the
germ cell overproliferation phenotype observed in Notch gain-of-function mutants
(Berry et al., 1997; Pepper et al., 2003). mett-10(oz36), which leads to the formation
of late-onset tumors, phenocopies the phenotype of glp-1 hyperactivation.
Interestingly, while we can demonstrate that METT-10 normally plays a role in
regulating germ cell proliferative fate (see below), mett-10(oz36) is a unique mett-10
allele in that it is the only allele that is ever tumorous on its own.
Because mett-10(oz36) has, with respect to germline proliferation, a
phenotype more severe than the null, mett-10(oz36) must have additional properties
beyond simple loss of METT-10 function that contribute to the tumorous phenotype.
Our genetic analysis indicates that mett-10(oz36) not only results in a loss of normal
METT-10 function, but also produces a protein that functionally poisons or interferes
with an unknown factor(s) to cause germline tumors; thus, the overproliferation
observed in mett-10(oz36) mutants is likely a synergistic phenotype that results from
simultaneous loss of mett-10 function and the function of at least one other unknown
factor. Our analysis here makes multiple predictions that will be helpful for the
identification of such a factor(s), including not only that disrupting its function should
enhance overproliferation of mett-10 simple loss-of-function alleles, but also that it
may physically interact with METT-10(oz36). The fact that it took this special allele
to recapitulate the glp-1/Notch gain-of-function phenotype highlights the redundancy
governing glp-1 signal inhibition and germ cell fate specification and suggests that
glp-1 occupies a unique “constriction point” in this complex genetic network. This is
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further supported by the identification of many negative regulators of Notch signaling
that act at multiple steps in the signal transduction process, as well as the redundancy
between the downstream pathways controlling meiotic entry (Sundaram and
Greenwald, 1993; Hubbard et al., 1997; Crittenden et al., 2003; Hansen and Schedl,
2006; Macdonald et al., 2008).
Although it took a unique allele to identify the role of mett-10 in inhibition of
germ cell proliferative fate, genetic analysis indicates that METT-10 normally
functions in this process. We find that mett-10 loss-of-function alleles can enhance
the tumorous phenotype of glp-1 gain-of-function mutations, while suppressing
premature meiotic entry upon reduction of glp-1 signaling.
How does METT-10 inhibit germ cell proliferation? Our observation that
METT-10 accumulates in nuclei as germ cells enter meiosis suggests that METT-10
may function in the nucleus to promote a switch from proliferative to meiotic fates.
One possibility is that it inhibits the pro-proliferative functions of active glp-1/Notch
signaling, since mett-10-associated overproliferation phenotypes resemble glp-1
hyperactivation and are exquisitely dependent on glp-1 activity. Moreover, genetic
pathway analysis suggests that mett-10 does not function in any of the characterized
meiotic entry pathways that act downstream of glp-1 signaling. While these data
suggest that METT-10 may negatively regulate glp-1/Notch signaling, it is still
possible that it acts in parallel to GLP-1. Moreover, we cannot say whether
METT-10 inhibits Notch signaling in general, as we were unable to detect clear
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genetic interactions with alleles of lin-12, the other C. elegans Notch receptor
(Methods).
Molecularly, it is likely that METT-10 functions as a methyltransferase, and
methylation is probably important for its function in proliferative fate specification.
METT-10 contains a well-conserved SAM-dependent methyltransferase fold, which
has been shown to bind SAM in the human protein (Wu et al., To be published.). The
mett-10(oj32) mutation, which disrupts a key SAM-binding residue, also disrupts the
balance between germ cell proliferation versus meiotic entry when examined in a
weak glp-1 gain-of-function genetic background. Almost all of the many
characterized proteins that contain a SAM-dependent methyltransferase fold function
as methyltransferases (Martin and McMillan, 2002). The two notable exceptions
include putrescine aminopropyltransferase (PAPT), which binds a decarboxylated
form of SAM (and not SAM itself) to catalyze the transfer of an amino-propyl group,
rather than a methylgroup, during spermidine synthesis (Korolev et al., 2002), and
Dnmt2, which contains a full methyltransferase fold, binds SAM, but lacks detectable
DNA methyltransferase activity (Dong et al., 2001). Although methyltransferases
can methylate protein, nucleic acid, small molecules, and lipids, in the absence of
close homologs with known functions and target specificity, the biochemical nature
of their target substrates cannot be easily predicted from protein or sequence structure
(Martin and McMillan, 2002). Thus, it is currently unclear what METT-10
methylates if it functions as a methyltransferase.
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Defects in proliferative fate specification are unlikely to be a downstream
consequence of the mett-10(-) RNAi defect
At all temperatures, mett-10 mutants are germ line RNAi resistant. However,
the role of METT-10 in RNAi is unlikely to be directly responsible for its phenotype
with regard to germ cell proliferation. There is no correlation between degree of
RNAi-defect and degree of overproliferation for mett-10 alleles. In addition, RNAimediated depletion of the C. elegans DICER homolog, dcr-1, does not enhance the
tumorous phenotype of the glp-1 gain-of-function allele, glp-1(oz264) (data not
shown). Finally, ego-1, an RNA-dependent RNA polymerase the contributes to
germline RNAi, acts in the opposite direction to mett-10 with respect to germ cell
proliferation; ego-1 was isolated as an enhancer of premature meiotic entry phenotype
of glp-1 loss-of-function, and strong ego-1 alleles exhibit premature meiotic entry
(Vought et al., 2005). Thus, it is unlikely that a general RNA interference defect is
responsible for the imbalance of proliferation over differentiation in mett-10 mutants,
although it is possible that the same biochemical or cellular functions of mett-10
underlie both phenotypes.

Loss of METT-10 function results in a diverse set of developmental phenotypes
In addition to inhibiting proliferative fate in the distal germline, mett-10
functions in multiple developmental contexts. The phenotype of mett-10 loss-offunction mutants, including abnormal morphology of the vulva and gonad, as well as
multiple defects in germ cell and embryonic development, are a testament to the
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potential diversity of mett-10 functions and targets. Interestingly, many of the defects
observed in these mutants, specifically those involving vulval morphogenesis and
apparent defects in mitotic progression of germ cells, are associated with defects in
cell division. Multiple screens for cell division mutants have been based on this
observation, including the one that lead to the identification of the mett-10(oj32)
allele (O'Connell et al., 1998; Fay and Han, 2000). This potential role for mett-10 in
enabling cell division, coupled with its developmental role as an inhibitor of
proliferative fate, highlights the importance of distinguishing the specification of
developmental cell fates from the cellular mechanisms that ensure their proper
execution.

MATERIALS AND METHODS
General worm culture and genetics
Standard procedures for culture and genetic manipulation of C. elegans strains
were followed (Brenner, 1974). To generate and screen for tumorous mutants, N2
Bristol animals were mutagenized with 50mM EMS, and a dissecting microscope was
used to screen an aged F2 generation for tumorous animals (Francis et al., 1995a).
For analysis of temperature sensitive phenotypes, hermaphrodites were allowed to lay
eggs overnight at 20˚C, were removed, and the plates were shifted to 25˚C for the life
of the F1 generation and phenotypes were scored at 1 day past the L4 stage at 25˚C.
All experiments analyzed only hermaphrodite germlines with the exception of the
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enhancement of gld-1(q485), in which male germlines were analyzed. However,
germline tumors were observed in rare, spontaneous smg-2(e2008); mett-10(oz36)
males, indicating that the effect of the oz36 mutation is not sex-specific.
Complementation testing between mett-10(oz36) and other mett-10 alleles was done
by crossing potential mett-10 alleles to the hT2[qIs48]gfp balancer, and then crossing
gfp(+) males to an unc-32(e189) mett-10(oz36) strain. Non-green, non-unc
hermaprodite progeny were picked to a new plate and shifted to 25˚C. To examine the
interaction between mett-10 and lin-12, we built double mutants between the lin12(n379) gain-of-function and mett-10(g38) or mett-10(oz36). No enhancement of
the multi-vulval phenotype of lin-12(n379) was observed, although mett-10(-)lin12(n379) animals lacking maternal gene product were very sick, grew slowly, and
had few progeny. mett-10 alleles obtained from the knockout consortium and NBPJapan were cleaned up by outcrossing to N2 Bristol 3X or recombining the markers
unc-32 and dpy-18 on and off the third chromosome. Strain constructions were
verified by single worm PCR and sequencing of alleles.
Alleles used in this study by chromosome:
I: smg-2(e2008), gld-1(q485), gld-2(q497)
II: gld-3(q730)
III: lin-12(n379), glp-1(oz264), glp-1(bn18), glp-1(q175), unc-32(e189), unc36(e251), mett-10(oz36), mett-10(g38), mett-10(tm2697), mett-10(ok2204), mett10(oj32), unc-119(ed3), dpy-18(e364), nDf40
IV: eri-1(mg366)
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Integrated Transgenes: ozIs7[pmett-10:mett-10::gfp; unc-119(+)] [chromosome I]
Extrachromosomal arrays: ozEx66 [pmett-10:mett-10::gfp; unc-119(+)],
ozEx63[pmett-10:mett-10;sur-5::gfp; unc-119(+)]

RNA interference and Western Blot Analysis
Clones for feeding RNAi against unc-22 and gld-1 were generated by PCR
amplification and cloning of 1kb exonic sequences into the pPD128.36 double T7
promoter vector. Clones were sequenced to verify identity, and transformed into the
E. coli host HT115(DE3). Feeding RNAi was performed at 20˚C as previously
described (Lee et al., 2007). Gravid adults were placed on RNAi plates and allowed
to lay overnight before removal. F1 L4 hermaphrodites were transferred onto fresh
RNAi plates, allowed to age for 24 hours, and then scored quantitatively for either
degree of paralysis (unc-22) by dissecting microscope or for phenotypes associated
with gld-1 dysfunction, including small oocytes and germ line tumors by DIC
microscopy. To quantitate degree of GLD-1 knockdown, 100 animals were washed,
boiled in 2X SDS sample buffer, and loaded onto an SDS-page gel. After transfer,
GLD-1 was detected by using a Rabbit anti-GLD-1 antibody at 1:1000, while the
LMN-1 control was detected using guinea pig anti-Celamin at 1:10,000.

Mapping of SAM-binding residues on C. elegans METT-10
Because of their structural nature and relatively low sequence conservation,
the mapping of previously characterized methyltransferase motifs (reviewed in
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(Malone et al., 1995) onto C. elegans METT-10 was done primarily by aligning the
C. elegans protein to human METT10D, a portion of which was crystallized in
complex with S-adenosyl methionine (SAM) by the Structural Genomics Consortium
[Structure (PDB 2H00) which can be found at:
http://www.rcsb.org/pdb/explore.do?structureId=2H00]. This was aided by
secondary structure prediction using Jpred3
[http://www.compbio.dundee.ac.uk/~www-jpred/]. As many methyltransferase motifs
are defined by their interaction with SAM, we examined the METT-10-SAM
interaction interface using RSCB ligand Explorer (available as a link through the
above website), which also served to define which residues are predicted to be
essential for SAM-binding.

Immunohistochemistry
Germline dissection, fixation, and staining was carried out as previously
described (Lee et al., 2007). Antibodies used were: monoclonal mouse anti-GFP
(mAb3E6) from Invitrogen (Cat# A-11120), Rabbit anti-GLD-1 (Jones et al., 1996),
Rabbit anti-phosphohistone-3 (Upstate, Cat#06-570), guinea pig anti-Celamin (gift
from J. Liu, Cornell), and donkey anti-mouse Alexa 594, goat anti-rabbit Alexa 488,
goat anti-rabbit Alexa 594, and goat anti-guinea pig-Alexa-488 obtained from
Molecular Probes (Invitrogen, CA). For EdU labeling and co-staining with
antibodies, we used a protocol modified from that of Sarah Crittenden (University of
Wisconsin-Madison, personal communication). To make EdU plates, a small culture
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of MG1693 E. coli (thymidine deficient bacteria, available from the E.coli stock
center) were grown overnight at 37˚C, and diluted 1/50 the next day in a solution of 1
% glucose, 1.25 µg/ml thiamine, 0.5µM thymidine, 1mM MgSO4, and 20µM EdU in
M9 minimal media. This was grown at 37˚C for 24 hours in the dark, before being
spun down, resuspended in a small volume of M9 and plated on 60mm M9 plates.
For labeling and staining of proliferative cells, worms were picked on to EdU,
washed off in PBS, dissected, and fixed for < 5 minutes in 3% paraformaldehyde/ /0.1
M K2HPO4 (pH 7.2) at room temperature. Germlines were taken through the normal
antibody staining protocol, including DAPI-staining, followed by the Click-IT EdU
reaction, performed according to the manufacturer’s instructions (Molecular Probes,
Cat#A10027).

Image capture and processing
Fluoresence micrographs were taken on a Zeiss compound microscope using
AxioPlan 2.0 imaging software and Hamamatsu camera. Each dissected and stained
gonad was captured as a montage, with overlapping cell boundaries. The montages
were then assembled in Adobe Photoshop CS3 and processed identically. The
boundary of each montage was processed using a feather tool of 20 pixels for each
image.
Confocal images were captured on a Perkin Elmer Ultraview Confocal
Microscope using a z-step of 1 micron. Where stated, multiple slices were assembled
into an extended focus image using Volocity image analysis software.
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Construction of transgenes and generation of transgenics
To create the initial METT-10::GFP construct, the entire METT-10 genomic
region, including 1.6 kb upstream and 1.9 kb downstream of the METT-10 coding
region was amplified as two PCR products meeting at the translational stop using
KOD DNA polymerase (Novagen, Cat # 71086), using the following primers: [ 5’
region: ATTA- NotI- GCGTCGTAGCCTGTGTTCAATTCC (F) and ATTABamHI-TCGGCATATTAAATTTTTCAAATACTGCACTAG (R)] and [3’ region:
ATTA-BamHI-TAAATAGCATAATTTTATTTATTCAATATTTATACC (F) and
ATTA-NotI- GGATACTGTATGTACAACTGATCTCTGAGC (R)]. This 5.5 kb
region includes parts, but not all, of the adjacent genes. These fragments were
digested with BamHI and NotI and ligated in a three-part ligation with NotI digestedpMM016 (Praitis et al., 2001), a plasmid containing the unc-119+ transformation
marker, to create pMM016(mett-10+). GFP(ivs):FLAG was amplified from
(pPD115.70, gift of Andrew Fire) and cloned into pMM016(mett-10+) using the
BamHI site. Proper orientation was determined by PCR, and the entirety of the mett10 region was sequenced to confirm integrity. To create low-copy integrated
transgenic lines, the microparticle bombardment method was used (Praitis et al.,
2001).

Mosaic analysis
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To generate arrays for mosaic analysis, pMM016 [mett-10+] was co-injected
with pTG96 [sur-5::gfp] (gift of Min Han’s lab) at concentrations of 20ng/ul and
80ng/ul, respectively. These arrays were crossed into smg-2(e2008); mett-10(oz36)
worms. Green animals were cloned individually at the L4 stage. After 2.5 days,
plates were screened for animals with green embryos or progeny to determine if the
array had passed through the germline. Animals were segregated based on germline
transmission, germlines were dissected, fixed briefly for 10’ in 3% paraformaldehyde
to preserve GFP fluorescence, DAPI stained, and mounted for scoring of germline
phenotype and GFP distribution.
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Table 1: The mett-10 (oz36) tumorous phenotype is the result of a poisonous
product
Genotype
temp (˚C)
% Tum
n
mett-10(oz36)
15
72
107
mett-10(oz36)
20
41
66
mett-10(oz36)/+
15
0
64
mett-10(oz36)/+
20
0
70
ozIs7[mett-10::GFP]; oz36
15
0
76
ozIs7[mett-10::GFP]; oz36
20
0
80
mett-10(oz36)/mett-10(ok2204)
15
0
32
mett-10(oz36)/nDf40
15
0
44
smg-2(e2008); mett-10(oz36)/+
20
0
54
smg-2(e2008); mett-10(oz36)/mett-10(g38)
20
18
40
smg-2(e2008); mett-10(oz36)
20
98
80
smg-2(e2008); glp-1 (bn18) mett-10(oz36)
15
0
128
smg-2(e2008); glp-1 (bn18) mett-10(oz36)
20
0
98
Full genotypes of the mutant combinations are: unc-32(e189) mett-10(oz36)/ nDf40
dpy-18(e364), unc-32(e189) mett-10 (oz36)/ mett-10(ok2204) dpy-18(e364), smg2(e2008); unc-36(e251) mett-10(oz36) / unc-119 (ed3), smg-2(e2008); unc-36(e251)
mett-10(oz36)/ unc-32(e189) mett-10(g38). All animals were m+, i.e. came from
mothers carrying a wild type copy of mett-10. Animals grown at 15˚C were scored at
3 days past L4 and animals grown at 20˚C were scored at 2 days past L4.
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Table 2: Loss of mett-10 function leads to multiple, temperature sensitive
phenotypes sensitive to maternal gene dose.
%
%
genotype
m temp
Pvl
%Ste
Mel
mett-10(oz36)
no
20
1
4
0
mett-10(oz36)
no
25
43
100
N.A.
mett-10(oz36)
yes
25
0
3
97
mett-10(g38)
no
20
2
7
0
mett-10(g38)
no
25
21
89
11
mett-10(g38)
yes
25
0
10
90
mett-10(tm2697)
no
20
10
19
0
mett-10(tm2697)
no
25
88
100
N.A.
mett-10(tm2697)
yes
25
0
2
98
mett-10(oj32)
no
20
0
18
0
mett-10(oj32)
no
25
11
100
N.A.
mett-10(oj32)
yes
25
0
0
100
mett-10(ok2204)
no
20
12
8
0
mett-10(ok2204)
no
25
98
99
N.A.
ozIs7[mett-10::GFP];mett-10(ok2204)
no
25
5
0
0
mett-10(ok2204)
yes
25
0
0
100

n
116
103
58
59
63
21
133
142
60
71
75
53
52
82
38
45

m= endogenous maternal gene product; Pvl= Protruding vulva; Ste = Sterile (no embryos
present); Mel = maternal effect lethal (lays dead embryos). All animals were scored 1
day past the L4 stage by DIC.
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Table 3: mett-10 inhibits proliferative fate in the C. elegans germline
%
Genotype
temp(˚C)
Tum
n
glp-1(oz264)
20
1
100
mett-10(ok2204)
15
0
54
mett-10(ok2204)
20
0
68
mett-10(oz36)
15
72
107
mett-10(oz36)
20
41
66
glp-1(oz264) mett-10(oz36)
20
100
72
mett-10(oj32)
15
0
72
mett-10(oj32)
20
0
48
glp-1(oz264) mett-10(oj32)
20
49
96
mett-10(tm2697)
15
0
68
mett-10(tm2697)
20
0
76
glp-1(oz264) mett-10(tm2697)
20
84
112
mett-10(g38)
15
0
78
mett-10(g38)
20
0
56
glp-1(oz264) mett-10(g38)
20
89
47
ozIs7[mett-10::gfp];glp-1(oz264) mett-10(g38)
20
0
56
All animals were m+, i.e. came from mothers carrying a wild type copy of
mett-10. Animals grown at 15˚C were scored at 3 days past L4 and animals
grown at 20˚C were scored at 2 days past L4.
Tumorous (Tum) includes proliferation throughout the germline, although
some germ cells in various meiotic stages may be observed.
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Table 4: Genetic interactions between mett-10 and known meiotic entry genes.
genotype

% Tum

n or reference

mett-10(oz36)

41

66

gld-1(q485)*

0

Francis et. al. (1995a)

gld-1(q485); mett-10(oz36)*

0

21

gld-2(q497)

2

Kadyk and Kimble (1998)

gld-2(q497); mett-10(ok2204)

0

102

100

98

gld-2(q497); glp-1(bn18) mett-10(oz36)

0

97

gld-2(q497); glp-1(q175) mett-10(oz36)**

0

44

gld-3(q730)

0

gld-2(q497); mett-10(oz36)

gld-3(q730); mett-10(oz36)

#

100

gld-3(q730); glp-1(q175) mett-10(oz36)**

0

Eckmann et. al. (2004)
$

47
28

*data from male germlines, as gld-1(q485) hermaphrodites have proximal proliferation due to
a return to mitosis (Francis et.al, 1995a).
**homozygous for unc-32(e189).
All data collected at 20˚C from animals with maternal mett-10 gene product, with the
exception of gld-3 strains (#), which make synthetic proximal proliferation tumors with mett10, and do not exhibit an increase in the length of the distal proliferative zone ($).
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Figure 1. mett-10 (oz36), a tumorous mutant. (A) A fluorescence micrograph of a
dissected, DAPI-stained wild type adult C. elegans hermaphrodite germline, with
schematic above. In the distal region proliferating germ cells (2) reside in close
contact with the somatic distal tip cell (1). At the transition zone (3), germ cells enter
meiosis, and proceed through meiotic prophase (4) to give rise to sperm in the L4
stage (6) and oocytes during adulthood (5). (B&C) Fluorescence micrographs of
distal germlines labeled for 3 hr with EdU from (B) wild type and (C) mett-10(oz36)
animals. White arrows mark the distal tip. (D-E) Extended focus projections of distal
germlines from (D) wild type and (E) mett-10(oz36) animals stained for the M-phase
marker phospho-histone-3 (pH3). Yellow dotted lines indicate the approximate
boundary of the proliferative and transition zones. All images are from animals
raised at 15˚C. Scale bar = 20 microns.
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Figure 2. C. elegans METT-10 encodes a putative methyltransferase. (A)
Alignment of the methyltransferase-10 domain of C. elegans METT-10 (GenBank
Acc# NP_499247), H. sapiens METT10D (GenBank Acc# NP_076991), and X.
laevis MGC81116 (GenBank Acc# NP_001085334). The architecture of the
methyltransferase domain is shown both by identification of methyltransferase motifs
(Malone et al., 1995), as well as secondary structure predictions with α-helices in
pink and ß-sheets in green (see methods). Motifs I, II, III, IV, V, and X were
identified by examination of the Human METT10D N-terminal crystal structure
(PDB 2H00), which did not include the region predicted to contain motifs VI and
VIII (see Methods). Previous work suggests that Motifs X, I, and III are primarily
responsible for binding to S-adenosyl methionine, (SAM) while Motifs IV, VI, and
VIII are primarily responsible for enzyme catalysis (Malone et al., 1995). Red arrows
show location of residues with significant contacts with SAM in the crystal structure
of human METT10D. mett-10(oj32) mutates the contacting glycine (G110, large red
arrow) in Motif I to an Arginine. This residue normal provides direct contact with the
methionine group of SAM. The overall structure and ability to bind SAM appears
highly conserved between orthologs, with the exception of an insertion of a predicted
(*) α–helix between ß4 and a5 in C. elegans. Not depicted is the C-terminal half of
the METT-10 protein, which may contain the target recognition domain, and is
significantly less conserved between orthologs. (B) Domain architecture of METT-10
marked with protein sequence changes caused by mett-10 alleles. Gray shading
highlights the conserved methyltransferase-10 domain.
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Figure 3: Loss of mett-10 function causes multiple temperature-sensitive somatic
defects. Vulva of (A) wild-type (B) mett-10(oz36) and (C) mett-10(ok2204) animals
raised at 25˚C. mett-10 mutants have the protruding vulva (Pvl) phenotype (arrow).
(D) A normal posterior region of intestine in a wild-type animal. White arrows mark
the borders of the intestinal lumen. (E) mett-10(oz36) and (F) mett-10(ok2204)
animals raised at 25˚C have distended intestinal lumens containing visible bacteria.
(G-H) Phenotypes of progeny of smg-2(e2008); mett-10(oz36) animals at 20˚C. (G)
Most embryos arrest during late embryonic development with visible vacuoles (black
arrows), (H) embryos are often abnormal in size (see small embryo on left), and (I)
the progeny that do hatch arrest shortly after with visible abnormalities (e.g. white
arrow).
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Figure 4: Germline phenotypes of mett-10(ok2204). (A) A one micron confocal
slice of the distal end of a wild type germline stained with the meiotic marker GLD-1.
(B) Confocal slices of representative distal germlines from mett-10(ok2204) m-zanimals raised at 25˚C and stained with an antibody against GLD-1. Phenotypes
range from small distal regions containing abnormally large nuclei (white arrows) to
gross morphological abnormalities with multiple gonadal protrusions (larger yellow
arrows). Many of the protrusions stain with the meiotic marker GLD-1, suggesting
that they are often filled with meiotic cells and do not represent duplications of the
distal tip. These gonad abnormalities are not observed for any mett-10 allele at 15˚C.
(C) A confocal slice of a wild type germline labeled with EdU for 4 hours at 15˚C and
stained with anti-phosphohistone-3 to mark cells in M-phase. With 4 hours of
labeling, essentially all cells within the proliferative zone are labeled. (D) A mett10(ok2204) germline labeled with EdU for 4 hours at 15˚C and stained for phosphohistone-3. Large, diffuse nuclei are visible in the distal region (white arrows); these
cells do not label with EdU in this time period and do not appear to be in M-phase
(absent for pH3). (E) Fluorescence micrograph of a wild type proximal germline
stained with an antibody against lamin to visualize oocyte nuclear positions. Wild
type animals produce a single row of oocytes. (F) The proximal germline of a mett10(ok2204) animal shifted from 20˚C to 25˚ for 2 days as an L4. Disorganization of
the oocytes and abnormal chromosomal morphology are visible. All scale bars = 20
microns.
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Figure 5: mett-10 disruption causes germ line RNAi resistance. (A) Effect of
feeding RNAi directed against the somatic gene unc-22. Strong unc-22 knockdown
causes partial paralysis and the “twitching” phenotype. (B) Effect of feeding RNAi
directed against the germ line-specific gene, gld-1. (C) Quantitation of degree of
GLD-1 knock down with Western analysis. The eri-1(mg366) “enhanced RNAi”
mutant does not suppress the mett-10 RNAi resistance phenotype.

75

Figure 6: mett-10(oz36) overproliferation is glp-1 dependent. Fluoresence
micrographs of germlines stained with DAPI to visualize DNA morphology (blue)
and for the meiotic marker GLD-1 (green). (A, A’) in wild-type hermaphrodites,
GLD-1 levels increase as germ cells enter meiosis and decrease as they transition
from pachytene to diplotene (Jones et al., 1996). (B, B’) homozygous mett-10(oz36)
animals raised at 15˚C exhibit a late-onset tumorous phenotype, as evidenced by an
increase in length of the distal proliferative zone and a spatial delay in GLD-1
accumulation. (C, C’) Disruption of nonsense-mediated mRNA decay with a mutation
in smg-2 significantly enhances the penetrance (Table 1) and degree of tumor
formation of mett-10(oz36) at 20˚C resulting in germlines containing proliferating
cells throughout. (D, D’) At the permissive temperature of 20˚C, glp-1(bn18)
hypomorphic temperature-sensitive mutants have only slight reductions in distal
proliferative zone size. (E, E’) glp-1(bn18) fully suppresses the tumorous phenotype
of smg-2(e2008); mett-10(oz36) animals at 20˚C. Scale bar = 20 microns.
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Figure 7. mett-10(g38) suppresses the temporal dynamics of premature meiotic
entry in glp-1(bn18). (A-I) Extended focus projections of distal germ lines stained
with DAPI to visualize DNA (blue) and for the M-phase marker phospho-histone-3
(pH3) (red). White dotted lines indicate the approximate boundary between the
proliferative and transition zones as defined by DNA morphology. (A-D) wild-type
and mett-10(g38) animals have similar proliferative zone size and number of pH3positive nuclei at 20˚C, and exhibit small decreases in the number of pH3-positive
nuclei upon a six hour shift to 25˚C. (E-F) Upon a six hour shift to 25˚C, no pH3positive nuclei can be found in glp-1(bn18). (G-H) After a six hour shift to 25˚C, glp1(bn18) mett-10(g38) germ lines still contain pH3- positive nuclei and retain a longer
proliferative zone than glp-1(bn18) alone. (I). After an 18 hour shift to 25˚C, no
pH3-positive nuclei can be found in glp-1(bn18) mett-10(g38) germ lines and nuclear
morphology is consistent with all cells entering meiosis with transition zone nuclei
located immediately adjacent to the distal tip (white arrow). (J) Quantification of AH. Scale bar = 20 microns.
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Figure 8: glp-1 activity is epistatic to gld-2(q497); mett-10(oz36) synthetic
tumors. (A) Simultaneous removal of gld-2 and mett-10 function does not cause
germ line tumors, but animals are sterile consistent with the meiotic defects seen in
gld-2(q497) mutants alone (Kadyk and Kimble, 1998). (B) The mett-10(oz36) allele
does form synthetic tumors with the gld-2 null. (C) gld-2(q497); mett-10(oz36)
tumors are suppressed by a weak glp-1 loss-of-function allele, glp-1(bn18).
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Figure 9. METT-10::GFP is a nuclear protein expressed in multiple cell types.
(A-C) Imaging of METT-10::GFP in live animals. (A) METT-10::GFP can be seen in
intestinal nuclei (intestine delineated by dashed line), (B) in the developing vulval
epithelium (white arrows; seen here at L4 stage), spermatheca (yellow dotted lines)
and (C) the adult vulva. (D-G) Fluorescence micrographs of METT-10::GFP
expression in the somatic gonad and germ line. METT-10::GFP is expressed in (D)
sheath cell nuclei, (E) the distal tip cell (white arrow), and (F) oocyte nuclei. Scale
bar = 20 microns.
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Figure 10. The pattern of METT-10::GFP accumulation in the distal germ line is
altered in glp-1 mutants. METT-10::GFP in the distal germ line. Proliferating germ
cells were labeled with a 3 hr pulse of EdU (red). METT-10::GFP (green)
accumulates in nuclei as cells enter meiosis, although some faint staining is also
observed in some proliferative nuclei. (B) A 6 hour shift of glp-1(bn18) animals to
25˚C results in almost all germ cells entering meiosis, and a concomitant shift in the
pattern of METT-10 accumulation. (C) glp-1(ar202gf) animals shifted for a day to
25˚C at the L4 stage form germ line tumors. Increased distal METT-10 is also
observed in many of these animals, although “low METT-10” patches are also
observed (regions encircled by white dotted lines). Scale bar = 20 microns.
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Figure 11: METT-10 is nuclear protein that does not colocalize with DNA.
Confocal slices of germ cells in meiotic pachytene expressing METT-10::GFP and
stained with mAB414 (which marks the nuclear pore, RED), anti-GFP (GREEN), and
DAPI (BLUE) to visualize nuclear morphology. Overlays show that METT-10::GFP
localizes predominantly within the nucleus, but does not overlap with the DNA.
Scale bar = 20 mi

85

Figure 12. mett-10 acts in the germ line to inhibit proliferative fate. To determine
the focus of METT-10 action in proliferative fate decisions, we carried out mosaic
analysis. A GFP - marked extrachromosomal array ozEx63 was generated by coinjection of a plasmid containing sur-5::gfp (Yochem et al., 1998) and a plasmid
containing pmett-10:mett-10(+). The array was crossed into the smg-2 (e2008); mett10 (oz36) background. Animals were individually scored for presence of the array in
the germ line (presence in progeny), cells of the somatic gonad (gonadal sheath and
distal tip cell), and the intestine. Location of array loss within the lineage was
inferred by the absence of GFP in all scored tissues descending from a given cell.
Germ lines were dissected, DAPI stained, and scored as Tumorous or Not Tumorous.
Green circle indicates presence of array, while open circle indicates absence. Loss of
the rescuing array in the germ line lineage results in a failure to suppress the fully
penetrant tumorous phenotype of the smg-2 (e2008); mett-10 (oz36) double mutant,
while loss in the somatic gonad is tolerated. One animal had one tumorous germ line
and one non-tumorous germ line, both with GFP+ somatic gonads. We infer that this
is likely a later loss in one of the germ line precursors Z2 or Z3.
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Chapter 3:
A role for dynein in the inhibition of germ cell proliferative fate
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INTRODUCTION
C. elegans germ cells proceed through a well-orchestrated developmental
program on their way to producing specialized gametes (Hubbard and Greenstein,
2005). The C. elegans gonad functions as an assembly line organized with a distal to
proximal polarity with respect to the uterus (Figure 1A). Proliferating germ cells,
including the germ line stem cells, reside in the distal region of the gonad that forms
the stem cell niche. These cells self-renew through mitosis, or at a certain frequency,
differentiate by entering meiosis and give rise to gametes after an extended meiotic
prophase (Figure 1B). As there is no evidence for asymmetric division of
proliferating germ cells, differentiation is likely a consequence of progressive
displacement away from the stem cell niche (Lin, 1997; Crittenden et al., 2006;
Morrison and Kimble, 2006).
The primary signal instructing germ cells to proliferate is activation of the glp1/Notch signaling pathway in the germ cells through interaction with the somatic
distal tip cell that expresses the Notch ligand LAG-2, which provides the stem cell
niche (Henderson et al., 1994; Hansen and Schedl, 2006; Kimble and Crittenden,
2007). Mutations that disrupt glp-1/Notch receptor function result in premature
differentiation and meiotic entry of germ line stem cells (Austin and Kimble, 1987),
while mutations that hyperactivate glp-1/Notch cause germ line tumors characterized
by germ cell overproliferation (Berry et al., 1997; Pepper et al., 2003).
Multiple factors act to restrain GLP-1-dependent germ cell proliferation
(Hansen and Schedl, 2006; Kimble and Crittenden, 2007). The C. elegans mett-10
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gene was initially characterized as an inhibitor of germ cell proliferative fate, but was
also shown to play a role in promoting progression through mitotic cell division and
meiotic development (Chapter 2). mett-10 encodes a putative methyltransferase that
is conserved in higher eukaryotes and a mutation that disrupts the binding pocket for
S-adenosylmethionine compromises the balance between proliferative and meiotic
fates (Chapter 2; Wu et al., To be published.). METT-10 accumulates in nuclei as
germ cells enter meiosis, consistent with its role in inhibiting proliferative fate and
promoting meiotic progression (Chapter 2). However, it is unclear how METT-10
nuclear accumulation is controlled, or if it is essential for METT-10 activity.
We find that inhibition of proliferative fate is also regulated by Dynein Light
Chain-1 and its partner, Dynein Heavy Chain-1; DLC-1 upregulates mett-10 RNA
levels and promotes the nuclear accumulation of METT-10 protein. Cytoplasmic
dynein is a large microtubule-associated motor complex that traffics organelles,
proteins, and RNAs toward microtubule minus ends (Karki and Holzbaur, 1999;
Carson et al., 2001; Vale, 2003). Dynein is required for many cellular processes,
including execution of mitotic cell division, a process necessary for cell proliferation
(Gonczy et al., 1999; Karki and Holzbaur, 1999; Schmidt et al., 2005). Thus, the
unexpected role of dynein in the inhibition of germ cell proliferative fate
demonstrates that proliferative fate is genetically separable from the act of mitotic cell
division itself, and addresses how cellular machinery can implement developmental
programs.
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RESULTS
Dynein Light Chain – 1 (DLC-1) inhibits germ cell proliferative fate
To identify proteins that function to inhibit the proliferative fate and may act
as functional partners of METT-10, we took advantage of available yeast two-hybrid
data for all conserved worm proteins (Li et al., 2004), and compiled a list of proteins
that interacted directly with METT-10 (primary interactors) and proteins that
interacted with the primary interactors (secondary interactors) (Figure 2). We
reasoned that if any of these proteins function with METT-10, they may also inhibit
proliferative fate. To test this, we depleted each of the interacting proteins by RNAi
in a genetic background sensitized to tumor formation by having excessive glp-1
activity [glp-1(oz264gf)] ((Kerins, 2006). We found five interactors that enhance the
glp-1(oz264) tumorous phenotype, and thus normally act as inhibitors of the
proliferative fate (Table 1 and Figure 2). This list of five interactors included dlc-1, an
LC8-type dynein light chain, and a component of the dynein motor complex that
participates in multiple processes, including minus-end directed protein trafficking
and mitotic cell division (Karki and Holzbaur, 1999; Giannakakou et al., 2000; Vale,
2003; Moseley et al., 2007; O'Rourke et al., 2007).
Although DLC-1 depletion causes germ line tumors in the glp-1(gf) sensitized
genetic background, it disrupts mitotic and meiotic processes in wild-type worms. In
addition to apparent polyploid nuclei, which are larger and contain more DNA, many
oocytes contained unpaired chromosomes (Figure 3, compare B and C). At first
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glance, these findings appear paradoxical because the germ line tumors in the glp-1
gain-of-function background require additional mitotic divisions. However, when we
assessed the degree of DLC-1 knockdown using antibody staining, we found that the
role of DLC-1 in inhibiting proliferative fate is uncovered in the glp-1 mutant
background because only a slight decrease in DLC-1 is needed to enhance the
tumorous phenotype of the glp-1(oz264) mutant without causing mitotic defects. In
contrast, more severe knockdown affects both cell fate and cell division, leading to
polyploidy (Figure 3F-J).
Although dynein light chains function within the context of the dynein motor
complex, other functions independent of the motor complex have been described
(Benashski et al., 1997; Herzig et al., 2000; Rayala et al., 2005; King, 2008). There
are multiple light chains, but inhibition of proliferative fate was unique to DLC-1
among the multiple dynein light chains we tested, including the closest dlc-1 paralog
dlc-2, the Roadblock-type light chain dyrb-1, and the Tctex-type light chain, dylt-1
(Figure 3A). Strikingly, RNAi-mediated depletion of Dynein Heavy Chain-1 (DHC1), the essential motor component of the dynein motor complex activity (Gonczy et
al., 1999), also increased tumor formation, suggesting that it plays a role in
proliferative fate specification (Figure 3A). We conclude, therefore, that DLC-1
affects the proliferative fate decision in the context of the motor complex, although it
is unique among the light chains in doing so.

The dynein motor complex promotes normal localization and levels of METT-10
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Similarly to dlc-1, loss of METT-10 also enhances germ cell proliferation and
formation of germ line tumors in the glp-1(oz264gf) sensitized genetic background
(Chapter 2). METT-10 accumulates in nuclei as cells enter meiosis, in line with its
functions in inhibiting proliferative fate and promoting meiotic development (Figure
4A). Our finding that DLC-1 depletion enhances the glp-1(oz264gf) tumorous
phenotype, coupled with the established role of dynein in trafficking proteins to the
nucleus (Karki and Holzbaur, 1999; Giannakakou et al., 2000; Moseley et al., 2007;
O'Rourke et al., 2007), suggested that DLC-1 may inhibit germ cell proliferative fate
through regulation of METT-10 nuclear accumulation. Using RNAi, we found that
DLC-1 knockdown decreases accumulation of a METT-10::GFP fusion protein in the
nucleus throughout the germ line, and also in somatic cells (Figure 4A-B, data not
shown).
To confirm that DLC-1 functions with the motor complex to promote METT10 nuclear accumulation, we tested whether reductions in DHC-1 activity also
resulted in a decrease in nuclear METT-10. We found that in a genetic background
with decreased DHC-1 function [dhc-1(or195)] (Schmidt et al., 2005), METT10::GFP nuclear accumulation is delayed, with a strong nuclear signal only in late
pachytene, rather than near transition zone as occurs in wild-type germ lines, in more
than 50% of germ lines (Figure 4C). This finding indicates that the dynein motor
complex promotes METT-10 nuclear accumulation.
In addition to diminished nuclear localization, overall staining intensity for
METT-10::GFP is reduced upon DLC-1 depletion, suggesting that DLC-1 also
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promotes or maintains the total METT-10 protein level (Figure 4B). Indeed,
immunoprecipitation of METT-10::GFP from animals treated with control RNAi or
RNAi against dlc-1, revealed that total METT-10::GFP levels are reduced by DLC-1
depletion (Figure 4D). This reduction does not reflect a decrease in germ line size,
because the levels of a ubiquitous germ line protein, CGH-1, were unchanged (Figure
4D).

DLC-1 regulates mett-10 RNA levels
We considered two potential mechanisms by which DLC-1 could regulate
total METT-10 protein accumulation. LC8-type dynein light chains regulate
transcription (Rayala et al., 2005; Rayala et al., 2006), and interact directly with
various proteins to regulate their subcellular localization and/or dimerization status,
which could alternatively affect protein stability (Schnorrer et al., 2000; Day et al.,
2004; Navarro et al., 2004; Barbar, 2008). To address whether DLC-1 regulates
METT-10 at the RNA level, we tested the effect of DLC-1 depletion on levels of
METT-10 mRNA using quantitative RT-PCR, and found that knockdown of DLC-1
results in a 4 to 5-fold reduction in mett-10 mRNA relative to the germ line
ubiquitous gene, cgh-1 (Figure 4E). Thus, DLC-1 promotes overall METT-10 RNA
levels, potentially through a transcriptional mechanism.

DLC-1 binds METT-10 in vitro
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We tested if DLC-1 directly interacts with METT-10 using GST pulldown
affinity chromatography, and found that 6XHis-tagged METT-10 binds GST-DLC-1,
but not other dynein light chains that show no effect on proliferative fate specification
(Figure 5A). We used a series of amino acid substitutions mutations in DLC-1 to see
if its interaction with METT-10 requires the same amino acid domain shown to
mediate LC8-type dynein light chain interaction with potential “cargo” proteins and
dynein intermediate chain (Navarro et al., 2004). Indeed, disruption of amino acid
residues F62, T67, and F73 in this motif greatly reduced binding to METT-10, while
mutation of H68 did not (Figure 5B), showing that the interaction between DLC-1
and METT-10 is similar to previously characterized interactions (Day et al., 2004).
In the course of analyzing the physical interaction between METT-10 and
DLC-1, we discovered that METT-10 strongly interacts with itself. We noticed an
SDS-stable supershifted band in the gel electrophoresis of some METT-10 proteins
equivalent to the expected size of a dimer (Figure 6A), in line with previous reports
that some methyltransferases require multimerization for function (Mallam and
Jackson, 2007; Tomikawa et al., 2008). The stable self-interaction domain of METT10 maps to the C-terminal region (aa 272-479), and a supershift was never seen with a
METT-10 N-terminal fragment that mimics the METT-10(oz36) truncation mutant
(aa 1- 271) alone (Figure 6A). To confirm that METT-10 binds to itself, we carried
out GST pulldown analysis between various METT-10 fragments and discovered that
while the METT-10(oz36) truncated protein does not exhibit the SDS-stable selfinteraction, it binds to both itself and to the METT-10 C-terminus in GST-pulldown
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analysis (Figure 6B). We also observed the supershifted band for 6XHIS-tagged
METT-10 proteins pulled down by GST-tagged METT-10 (Figure 5C, 6B),
suggesting that METT-10 may exist in an oligomeric form. Interestingly, the putative
METT-10 dimer is pulled-down by DLC-1, indicating that the C-terminal interface by
which METT-10 interacts with itself is independent of the interface used to bind
DLC-1 (Figure 5C).

DLC-1 and the METT-10 nuclear localization signal (NLS) act redundantly to
ensure METT-10 nuclear accumulation
The finding that DLC-1 interacts with METT-10 raised the possibility that
DLC-1 directly participates in METT-10 nuclear accumulation. Although the two
proteins did not colocalize in vivo (Figure 7), it is possible that a transient interaction
is sufficient to mediate the effect of DLC-1 on METT-10 localization. To address
whether DLC-1 promotes METT-10 localization through direct binding, we needed to
specifically test the contribution of DLC-1-interaction to METT-10 nuclear
accumulation in vivo. To this end, we mapped the residues in METT-10 that interact
with DLC-1. Previous work showed that LC8-type light chains interact with a short
peptide sequence in their target proteins, usually conforming to either a (S/K)XTQT
or GIQVD sequence motif (Benison et al., 2007; Barbar, 2008), but METT-10 does
not have either of these motifs. We thus tested a series of METT-10 C-terminal
truncations (data not shown), followed by individual amino acid replacements in an
eight amino acid region for their ability to interact with DLC-1 in GST pulldown
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experiments. Mutation of METT-10 amino acid residues D420, N421, S423, and
Q424 to alanine severely compromised binding to DLC-1, thus defining the METT10 motif that interacts with DLC-1 as “DNASQ” (Figure 5D).
To determine the effect of DLC-1-binding on METT-10 localization in vivo,
we constructed a transgenic version of METT-10::GFP in which the “DNASQ” motif
was mutated to “AAAAA” (5A mutant, Figure 8A), and compared the localization of
METT-10::GFP constructs within gonadal sheath cells, which are large cells that
express METT-10 at high levels and thus are easy to visualize. Wild type METT10::GFP is concentrated in the nucleus (Figure 4A, 8B), and disruption of the
DNASQ motif that interacts with DLC-1 reduces, but does not eliminate, nuclear
METT-10::GFP (Figures 4F, 8C).
In addition to the DLC-1 binding motif, METT-10 also contains a potential
nuclear localization sequence (ARKRAKA), raising the possibility that this may act
redundantly with the DLC-1 binding site to enable METT-10 nuclear accumulation.
Supporting this idea, deletion of the putative METT-10 nuclear localization signal
(NLS) alone does not block nuclear entry (Figure 7D), but simultaneous disruption of
both the NLS and the DLC-1 binding site makes METT-10 predominantly
cytoplasmic (Figure 8E).

Cytoplasmic METT-10 rescues most mett-10 mutant phenotypes
Identification of at least two pathways promoting METT-10 nuclear
accumulation enabled us to address if METT-10 nuclear accumulation is essential in
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vivo, and whether the METT-10:DLC-1 physical interaction is vital to METT-10
function. To this end, we compared the abilities of the integrated transgenes
expressing various mutant forms of METT-10 to rescue mett-10 mutant phenotypes.
These included METT-10 with a mutant DLC-1 binding site (mett-10(5A)::gfp), a
mutant DLC-1 binding motif and deletion of the NLS (mett-10(-NLS, 5A)::gfp), and
METT-10 with a mutant DLC-1 binding site and a mutation in the catalytic core that
should reduce the methyltransferase activity (mett-10(G110R,5A)::gfp) (see
Methods). We compared expression of RNA and protein by the various transgenes
using qRT-PCR and western blots (Figure 9, Methods). The RNA and protein levels
of wild type and mutant transgenes are similarly correlated, agreeing with the finding
described above that DLC-1 promotes METT-10 levels primarily by regulating mett10 RNA levels.
Each mett-10 transgene was tested for its ability to suppress several mett-10
mutant phenotypes, including abnormalities in somatic and germ cell development
observed in the mett-10 null background, defective proliferative fate specification
caused by loss-of-function mett-10 mutations, and germ line RNAi resistance
(Chapter 2).
Loss of mett-10 function causes protrusion of the vulva, irregular gonadal
shape, and defects in germ cell development leading to a sterile phenotype when
animals are raised at 25˚C (Chapter 2). While a methyltransferase-defective
transgene failed to suppress any defects, mett-10(5A)::gfp and mett-10(-NLS, 5A)::gfp
transgenes fully suppressed the protruding vulva phenotype and partially suppressed
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abnormalities in gonad shape and germ cell development (Table 2A). This partial
suppression suggests that the degree of METT-10 nuclear accumulation, promoted by
both DLC-1-interaction and the NLS, facilitates METT-10 functions, but is not
essential. Moreover, even in the absence of both the DLC-1 interaction site and the
NLS, some residual METT-10 may still enter the nucleus (some nuclear puncta can
be seen for mett-10(-NLS;5A)::gfp, Figure 8E), causing partial suppression. The fact
that methyltransferase-defective transgene does not rescue any of these phenotypes
demonstrates that that enzymatic activity is required for METT-10 function, and it is
possible that even if the critical METT-10 targets are nuclear proteins, METT-10 may
also modify them in the cytoplasm before they enter the nucleus.
Loss of mett-10 function compromises the balance between germ cell
proliferation and differentiation that, similarly to dlc-1 and dhc-1, are revealed in a
glp-1 hyperactivation mutant background (Chapter 2). Thus, to evaluate the role of
METT-10 nuclear accumulation in proliferative fate specification, we tested for
rescue of the tumorous phenotype of glp-1(oz264gf) mett-10(g38) double mutants.
Expression of METT-10(5A)::GFP and METT-10(-NLS,5A)::GFP rescued the
tumorous phenotype of glp-1(oz264) mett-10(g38) animals, but a methyltransferasedefective version of METT-10 did not (Table 2B). Thus, METT-10 inhibition of
proliferative fate, similarly to other METT-10 developmental functions, requires
enzymatic activity, but not the full extent of nuclear accumulation that is mediated by
its NLS and DLC-1.
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Mutation of mett-10 causes germ line RNAi resistance. To assess whether the
mutant transgenes rescue the RNAi pathway defect of mett-10 mutants, we asked
whether expression of METT-10(5A)::GFP or METT-10(-NLS;5A)::GFP could
restore mett-10(ok2204) susceptibility to dsRNA directed against the germ line gene,
gld-1. We found that, similarly to other mett-10 phenotypes, expression of the mutant
proteins could at least partially rescue RNAi resistance (Figure 10).

Cytoplasmic retention does not underlie the poisonous nature of METT-10(oz36)
The role of METT-10 in proliferative fate specification was initially revealed
by the antimorphic mett-10(oz36) truncation mutant, which exhibits germ line tumors
even in the presence of wild type glp-1 (Chapter 2). The dose-dependence of the
tumorigenic effect of METT-10(oz36) suggested that it is a “poisonous” protein that
disrupts the function of at least one other unknown factor that normally inhibits
proliferative fate (Chapter 2). Interestingly, METT-10(oz36) lacks both an NLS and
a DLC-1 binding site, and thus is predominantly cytoplasmic (Figure 8A,F),
suggesting that this change in localization may contribute, in part, to its poisonous
nature.
We tested the hypothesis that cytoplasmic retention of METT-10(oz36) plays
a causal role in tumor formation by testing our cytoplasmically-retained METT-10
transgene (mett-10(-NLS,5A)::gfp) for the ability to suppress METT-10(oz36)induced tumors. In addition, we tested whether driving METT-10(oz36) into the
nucleus by fusing it to the SV40 NLS could also suppress the tumorous phenotype.
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We found that expression of cytoplasmic METT-10 could completely suppress
METT-10(oz36) overproliferation. Moreover, the nuclear version of METT10(oz36), METT-10(oz36::SV40NLS)::GFP, enhanced the tumorous phenotype of
METT-10(oz36) (Figure 8G, Table 2). Together, these data reinforce the idea that
METT-10(oz36) has a dose-dependent effect on tumor formation, and further suggest
that this effect is independent of the cytoplasmic localization of the mutant protein.
Interestingly, we also found that a methyltransferase-defective version of
METT-10 could suppress METT-10(oz36) induced tumor formation, suggesting that
METT-10(oz36) acts as a poison by binding to and interfering with the function of
another protein and/or molecule; a methyltransferase-defective version of METT-10
could compete with METT-10(oz36) for binding and relieve this effect.
Alternatively, since METT-10(oz36) can bind full-length METT-10 (Figure 6B), a
methyltransferase-defective METT-10 could bind METT-10(oz36) itself and
neutralize its poisonous activity.

Dynein regulates proliferative fate independently of METT-10
Based on the above observations, one possible explanation for the
enhancement of glp-1(oz264gf) tumor formation by DLC-1 depletion is the reduced
METT-10 accumulation caused by decreased mett-10 RNA, combined with decreased
transport of METT-10 to the nucleus. However, genetic interactions between mett-10,
dlc-1 and dhc-1 indicate that dynein also plays roles in proliferative fate specification
independent of its effects on METT-10 protein accumulation.
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RNAi knockdown of DLC-1 enhances tumor formation in the mett-10(oz36)
genetic background (Table 3A). Two different weak loss-of-function heavy chain
alleles, dhc-1(or195) (Schmidt et al., 2005) and dhc-1(js319) (Koushika et al., 2004;
Schmidt et al., 2005), also specifically enhanced the mett-10(oz36) tumorous
phenotype, although the dhc-1(js121) allele did not (Table 3B). Because METT10(oz36) cannot detectably interact directly with DLC-1, the ability of DLC-1
knockdown and dhc-1 reduction-of-function mutants to further enhance tumor
formation indicates that DLC-1 also regulates proliferative fate independently of its
effects on METT-10.

METT-10 and dynein may function together in multiple contexts
The dhc-1(js319) dynein heavy chain mutation did not cause tumors when
combined with loss-of-function mett-10 alleles, but the double mutant animals had a
fully penetrant sterility not seen in either mutant alone. On closer examination, dhc1(js319); mett-10(-) germ lines exhibited two primary defects reminiscent of the
phenotypes caused by RNAi knockdown of DLC-1: polyploidy in the distal region
and unpaired chromosomes in diakinesis (Figure 11 and Table 4). We also saw these
phenotypes at low penetrance in dhc-1(js319) animals, but they are distinct from the
cell cycle progression defects observed in mett-10 single mutants (Chapter 2). Thus,
loss of mett-10 function enhances a hypomorphic dhc-1 allele, causing phenotypes
typical of dynein loss of function mutations. This indicates that METT-10 also
facilitates the function of the dynein motor complex in cell division and meiosis.
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Complete loss of mett-10 function alone does not cause these phenotypes, indicating
that mett-10 function in cell division and meiotic events is not essential unless dynein
function is partially compromised.
Reduction in glp-1 activity suppresses germ line overproliferation, but not the
polyploidy and unpaired chromosome phenotypes of dhc-1; mett-10(oz36) double
mutants (Tables 3 & 4). Thus the roles of mett-10 and dynein in cell division and
meiotic events can be separated from their roles in regulation of the proliferative fate
decision. We conclude, therefore, that regulation of proliferative fate, perhaps through
negative regulation of glp-1 signaling, is only one cellular function in which dynein
and METT-10 cooperate.
Interestingly, we also found that expression of a METT-10 protein unable to
directly interact with DLC-1, METT-10(5A)::GFP, results in polyploidy in the distal
region of the germ line, a phenotype reminiscent of loss of dlc-1 function (Figure 4F,
compare with Figure 3C). The penetrance of this phenotype correlated with the level
of transgene expression and was suppressible by RNAi directed against GFP (data not
shown). This dominant phenotype suggests that METT-10(5A)::GFP acts as a
dominant negative with respect to some dlc-1 functions, potentially through
disruption of a complex made up of METT-10, DLC-1, and other proteins.

dhc-1(js121), dhc-1(jor195), and dhc-1(js319) each affect a different functional
domain of Dynein Heavy Chain-1
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The differential genetic interactions between dynein heavy chain-1 and mett10 alleles with respect to proliferative fate specification, cell division, and meiotic
pairing/recombination, may be due to the nature of the dhc-1 mutations, which affect
different parts of the heavy chain locus (Figure 12). The mutant with the strongest
effect on tumor formation but no effect on the polyploidy/univalent phenotype, dhc1(or195), was previously shown to carry a missense mutation in the microtubule stalk
domain (Figure 12 and O'Rourke et al., 2007), which mediates the interaction of the
motor complex with microtubules and plays a key role in determining the direction of
motility (Carter et al., 2008). Sequencing of dhc-1(js319), which has strong genetic
interactions with mett-10 affecting tumor formation, polyploidy, and chromosome
pairing, reveals a AG>AA mutation in the splice acceptor for exon 13. If we assume
that this mutation results in exon skipping, this would result in a truncation Cterminal to the 5th and 6th “ATP-ase-like” domains; this region has no known function.
Finally, dhc-1(js121) is predicted to have the most severe effect on dynein function,
as it is an AG>>AA mutation in the splice acceptor for exon 6, which encodes the
linker domain immediately preceeding the first ATPase domain (Figure 12). The
linker domain is thought to play an essential role in dynein motility (Burgess et al.,
2003). Both dhc-1(or195) and dhc-1(js319) behave as temperature-sensitive, weak
dynein heavy chain alleles, especially at the permissive temperature of 20˚C and in
the presence of maternal gene product. On the other hand, dhc-1(js121), which is
predicted to have the most severe effect on dynein function, behaves as a stronger
loss-of-function [dhc-1(js121) homozygotes are sterile]. Thus, dhc-1(js121) may fail

104

to enhance mett-10(oz36) because of pleiotropic effects that mask any role in
proliferative fate specification.

DISCUSSION
Dynein inhibits specification of proliferative fate in the C. elegans germ line
The genetic and molecular studies presented here demonstrate that the dynein
motor protein complex inhibits the decision of germ cells to proliferate in the C.
elegans germ line, despite being necessary for the execution of mitotic cell division in
those cells that do proliferate. The evidence further indicates that Dynein regulates
this cell fate decision in part by promoting expression and function of the METT-10
putative methyltransferase that inhibits proliferative fate, and in part through a
METT-10-independent pathway.

DLC-1 regulates METT-10 RNA levels and protein subcellular localization
DLC-1 knockdown reduces both METT-10 RNA and protein levels. The
mammalian LC8-type dynein light chain, DLC1, localizes to chromatin and acts in a
transcriptional transactivation complex with estrogen receptor (Rayala et al., 2005),
raising the possibility that DLC-1 could directly regulate mett-10 transcription. It is
also possible that DLC-1 normally promotes mett-10 RNA stability, or enables the
nuclear localization of other proteins that ensure adequate mett-10 transcription.
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The direct physical interaction between DLC-1 and METT-10 reported here
appears to play a redundant, non-essential role in METT-10 function. We showed that
nuclear localization signal (NLS)-mediated and dynein-mediated pathways act
redundantly to ensure normal METT-10 nuclear accumulation. The role of dynein and
the microtubule network, and specifically LC8-type light chains, in facilitating the
nuclear import of proteins is well documented (Giannakakou et al., 2000; Trostel et
al., 2006; Moseley et al., 2007; Roth et al., 2007; Desfarges et al., 2009; Shrum et al.,
2009). However, in cases where it has been examined, dynein mediates nuclear
accumulation by enhancing the efficiency of NLS-dependent nuclear import
(Moseley et al., 2007; Roth et al., 2007). In these cases, unlike the example of
METT-10, nuclear accumulation still requires an intact NLS. Thus, our work reveals
a qualitatively different role for dynein, and LC8/DLC-1 interaction, in mediating
nuclear accumulation. We cannot rule out the possibility, however, that DLC-1
specifically promotes the function of a secondary, non-canonical NLS in METT-10.
When we specifically disrupted NLS- and DLC-1- mediated METT-10
nuclear accumulation in vivo, we found that it plays a non-essential role in most mett10 developmental functions. Because our double mutants still retain some residual
nuclear METT-10, a small nuclear pool may be sufficient to carry out its function as a
methyltransferase. It is also possible that METT-10 association with dynein is
transient, and promotes modification of target molecules on their way to the nucleus,
with METT-10 nuclear accumulation as a byproduct. In this scenario, cytoplasmic
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METT-10 would be able to modify targets in the cytoplasm before their transport to
the nucleus.
While DLC-1 may inhibit proliferative fate in part through promotion of
normal METT-10 activity, it is clear that DLC-1 (and dynein) inhibit proliferative
fate by other means as well, since disruptions in dynein function enhance germ line
tumor formation of the mett-10(oz36) cytoplasmic mutant. Interestingly, disruptions
of dynein function do not cause germ line tumors in other mett-10 mutant
backgrounds, including the null. Since METT-10(oz36) is proposed to “poison” the
function of another gene product through an unproductive physical association
(Chapter 2), it is possible that dynein promotes the normal function of the gene
product(s) poisoned by METT-10(oz36), thus sensitizing mett-10(oz36) to
perturbations in dynein function. Moreover, it is likely that METT-10, dynein, and
this “poisoned factor” function to negatively regulate the pro-proliferative functions
glp-1/Notch signaling, as the mett-10(oz36); dhc-1(or195) tumors are exquisitely
sensitive to the levels of glp-1 activity.

METT-10 and dynein function together in cell division and meiosis
While METT-10 and the dynein motor complex function together to inhibit
germ cell proliferative fate, we also uncovered a role for METT-10 in other dyneindependent processes. Specifically, decreases in METT-10 activity enhance the mitotic
and meiotic defects of a weak dynein heavy chain loss-of-function allele, leading to
highly penetrant sterility, polyploidy, and unpaired chromosomes in diakinesis.
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Interestingly, O’Connell and colleagues identified a phenotype in mett-10(oj32) lossof-function mutants similar to those seen in dynein loss of function mutants
(O'Connell et al., 1998). Specifically, mett-10(oj32) embryos have a visible defect in
the flattening of the posterior centrosome during the first asymmetric division
(O'Connell et al., 1998). The function of centrosome flattening is unclear, but may be
caused by the dynein-dependent force that pulls the posterior centrosome towards the
posterior pole, thus ensuring asymmetric division (Severson and Bowerman, 2003;
Nguyen-Ngoc et al., 2007). Importantly, defects in centrosome flattening are also
observed for perturbations in dynein and dynactin function (Severson and Bowerman,
2003; Schmidt et al., 2005; Couwenbergs et al., 2007). Together these data suggest
that METT-10, perhaps through its interaction with DLC-1, functions to promote
multiple dynein-dependent events, although the mechanisms remain unclear.
Moreover, if METT-10 and dynein jointly function in proliferative fate specification,
cell division, and meiotic pairing and/or recombination, then the normal function of
METT-10 in all these processes may be to promote dynein activity, which in turn
promotes METT-10 function in a positive feedback loop.

Proliferative and anti-proliferative roles of dynein
The dynein motor complex participates in a diversity of processes, including
nuclear movements, spindle assembly and orientation, mitotic checkpoint
inactivation, organelle movement, and endocytosis (Henderson et al., 1994; Karki and
Holzbaur, 1999). Here we show that dynein inhibits the specification of germ cell
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proliferative fate, despite also being necessary for mitotic cell division in proliferating
cells. These “anti-proliferative” (cell fate) and “pro-proliferative” (cell fate
execution/cell division) functions of dynein are not unique to the maintenance of the
balance between proliferation and differentiation in the C. elegans germ line. The
essential roles of dynein in the execution of cell division are well known (Karki and
Holzbaur, 1999), as is its role in promoting the activity of tumor suppressors,
including p53, by facilitating their nuclear transport (Giannakakou et al., 2000;
Fabbro and Henderson, 2003; Trostel et al., 2006; Roth et al., 2007). Moreover, in
keeping with its many cellular functions, the dynein motor complex influences
multiple cell fate decisions by a diversity of mechanisms. These include the
trafficking of cell fate determinants, such as egalitarian and its associated oskar
mRNA (Navarro et al., 2004), spindle positioning during asymmetric division
(Couwenbergs et al., 2007), ensuring the normal timing of mitotic cell division (Fan
and Ready, 1997), and now by promoting RNA levels and protein nuclear
accumulation of a factor influencing cell fate. Thus dynein acts as a “handyman”,
performing many of the jobs necessary to execute a developmental program.
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MATERIALS AND METHODS
General worm culture and genetics
Standard procedures for culture and genetic manipulation of C. elegans strains
were followed (Brenner, 1974). Strain constructions were verified by single worm
PCR and sequencing of alleles.
Alleles used in this study by chromosome:
I: rrf-1(pk1417), dhc-1(js319), dhc-1(or195), dhc-1(js121)
III: mett-10(oz36)[antimorph], mett-10(g38) [hypomorph], mett-10(tm2697)
[hypomorph], mett-10(oj32)[hypomorph], mett-10(ok2204)[null], glp-1(oz264gf), glp1(bn18ts)
Integrated Transgenes:
ozIs7[pmett-10:mett-10::gfp; unc-119(+)]
ozIs9[pmett-10:mett-10(5A)::gfp; unc-119(+)] (LOW)
ozIs11[pmett-10:mett-10(5A)::gfp; unc-119(+)] (HIGH)
ozIs15[pmett-10:mett-10(oj32,5A)::gfp; unc-119(+)] (line1)
ozIs16[pmett-10:mett-10(oj32,5A)::gfp; unc-119(+)] (line2)
ozIs20[pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)](line 1)
ozIs21[pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)](line 2)
ozIs19 [pmett-10::mett-10(oz36)::gfp; unc-119(+)]
ozIs25[pmett-10::mett-10(oz36::SV40NLS)::gfp; unc-119(+)]
Extrachromosomal arrays:
ozEx66 [pmett-10:mett-10::gfp; unc-119(+)]
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ozEx69 [pmett-10:mett-10(-NLS)::gfp; unc-119(+)]
ozEx67 [pmett-10:mett-10(5A)::gfp; unc-119(+)]
ozEx72 [pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)]
ozEx73 [pmett-10:mett-10(oz36)::gfp; unc-119(+)]
ozEx74[[pmett-10:mett-10(oz36::SV40NLS)::gfp; unc-119(+); pmyo-2::mcherry]

Sequencing of dhc-1 alleles
To sequence the entirety of the dhc-1 locus, including introns and exons,
primers amplifying 1kb regions and containing 200 bp overlap on either side were
used to amplify fragments that spanned the entire dhc-1 locus, including
approximately 200bp upstream and downstream of transcriptional start and stop, and
all introns from the dhc-1(js319) and dhc-1(js121) mutants. These were then cleaned
and sequenced, assembled using SeqMan (DNAstar), and aligned to the N2 dhc-1
sequence from wormbase to identify mutations.

Immunohistochemistry
Germ line dissection, fixation, and staining was carried out as previously described
(Lee et al., 2007). Antibodies used were: monoclonal mouse ant-GFP (mAb3E6)
from Invitrogen (Cat# A-11120) at 1/100, Rabbit anti-DLC-1 at 1/10 (see below) and
donkey anti-mouse Alexa 594, goat anti-rabbit Alexa 488, goat anti-rabbit Alexa 594
at 1/400, obtained from Molecular Probes (Invitrogen, CA). EdU labeling and costaining with antibodies was carried out as described in (Chapter 2).
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Generation of anti-DLC-1 antibody and quantification of DLC-1 levels
To generate the GST:DLC-1 fusion protein, full length DLC-1 was cloned
into the pGEX-5x-3 vector (GE Healthcare Life Sciences, Cat# 27-4586-01).
Inductions were carried out in the E. coli strain BL21(DE3) (Sigma, MO). From an
overnight starter culture grown at 30˚C, cultures were diluted and grown at 37˚C until
they reached an OD of 0.5. Cells were induced with 1mM IPTG for 3 hours at 37˚C.
Cells were harvested and GST-DLC-1 was then extracted essentially as described in
(Sambrook and Russell, 2001) and injected into rabbits by Pocono Rabbit Farm &
Laboratory (Canadensis, PA). Sera were affinity purified against a 6XHIS:DLC-1
fusion protein. To make 6XHIS:DLC-1, DLC-1 was amplified from pGEX (DLC-1),
and cloned into pTRCHIS (Invitrogen, Cat # K4410-01, K4410-40).
pTRCHIS(DLC-1) was transformed into BL21(DE3) cells, and cultures were induced
similarly to GST-DLC-1. 6XHIS-DLC-1 was extracted under native conditions using
Ni-NTA agarose (Qiagen, Cat# 30210). 6XHIS-DLC-1 was subsequently coupled to
Cyanogen-Bromide activated Sepharose (Sigma, MO, Cat# C9142) and antibody
purification was carried out essentially as previously described (Jones et al., 1996).
Specificity was determined both by Western (where antibody recognizes a single
10kDa band) and by antibody staining of germ lines and intestines from animals
treated with and without dlc-1 RNAi.
For quantification of DLC-1 levels (in Figure 2J), raw images of DLC-1
staining were imported into Image J, germ lines were traced, and average pixel
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intensity was calculated. All pixel intensities were then normalized to represent %
knockdown by dividing the pixel intensity for the sample by the average DLC-1 pixel
intensity for glp-1(oz264) germ lines fed control RNAi and multiplying by 100.

Image capture and processing
Fluorescence micrographs were taken on a Zeiss compound microscope using
AxioPlan 2.0 imaging software and Hamamatsu camera. Each dissected and stained
gonad was captured as a montage, with overlapping cell boundaries. The montages
were then assembled in Adobe Photoshop CS3 and processed identically. The
boundary of each montage was processed using a feather tool of 20 pixels for each
image.

Confocal images were captured on a Perkin Elmer Ultraview Confocal

Microscope using a z-step of 0.3 microns.

RNAi screen of METT-10 interactors
RNAi clones were either purchased from Open Biosystems or generated by
PCR amplification and cloning of 1kb exonic sequences into the pPD128.36 double
T7 promoter vector, sequenced to verify identity, and transformed into the E. coli host
HT115(DE3). Feeding RNAi was performed as previously described (Lee et al.,
2007), in rrf-1(pk1417), rrf-1(pk1417); glp-1(oz264gf), and rrf-1(pk1417); mett10(oz36) backgrounds at the permissive temperature (20oC). F1 L4 hermaphrodites
were transferred onto fresh RNAi plates and scored quantitatively for germ line
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tumors 48 hrs later by DIC microscopy. In the course of the screen, it came to our
attention that mett-10 mutants are relatively resistant to germ line RNAi.

Construction of transgenes and generation of transgenics
The initial mett-10::gfp construct includes 1.6 kb upstream and 1.9 kb
downstream of the METT-10 coding region with GFP(ivs):FLAG inserted
immediately before the translational stop cloned into the pMM016 vector containing
the transformation marker, unc-119(+) (Chapter 2). Mutations of the mett-10 coding
region, including NLS deletion, DNASQ>AAAAA, methyltransferase-mutation
(G110R), and deletion of coding sequences downstream to the mett-10(oz36)
premature stop codon, were done with sewing PCR (Lee and Schedl, 2001). To
create mett-10(oz36::SV40NLS)::gfp, the sequence
“CAAAATCGTCTGCCAAAGAAGAAGCGTAAGGTA” encoding the SV40NLS
was inserted immediately prior to GFP using sewing PCR and the mett-10(oz36)::gfp
construct as a template. To create low-copy integrated transgenic lines, the
microparticle bombardment method was used (Praitis et al., 2001). Generation of
extrachromosomal arrays was done by injection pMM016(mett-10) plasmids at a
concentration of 40ng/ul into unc-119(ed3) worms.

GST-pulldowns
Full length METT-10 (C. elegans coding region ZK1128.2a), METT10(oz36) (aa 1-271), or METT-10(Cterm) (aa 272-479) were amplified from N2

114

Bristol cDNA and cloned into pTRCHIS (Invitrogen, Cat # K4410-01, K4410-40),
sequenced, and transformed into BL21(DE3) (Sigma, MO) cells for expression.
Proteins were expressed under the same conditions as GST-DLC-1 (above). For GST
pulldowns, bacterial extracts were resuspended in PBS + protease inhibitors and
sonicated. Cleared cell extracts were added directly to 5ug of GST-DLC-1 already
bound to Glutathione-sepharose in 20mM Tris pH 7.5, 500mM NaCl, 0.5% NP40,
and 1X protease inhibitors. Binding reactions were carried out overnight at 4˚C,
washed 4X with 10mM Tris pH 7.5, 150mM NaCl, and 0.1% NP40. Western blot
analysis using an anti-6XHIS antibody (Amersham Biosciences, Cat# 27-4710-01)
was performed from beads boiled in SDS-sample buffer with BME. Point mutations
in METT-10 and DLC-1 were generated using sewing PCR or site-directed
mutagenesis.

Immunoprecipitation and Western Analysis
To generate enough worms for IP-Western of METT-10:GFP (flag), we
resuspended worms from ten 60mm overgrown plates of each transgenic line in 5%
lactose and 10X OP50 or 1X bacterial expressing dsRNA and plated these onto ten
100mm plates, which were shifted to 25˚C to maximize transgene expression. After
two days, worms were washed off in PBS and extracts and IPs were carried out
essentially as described in (Guang et al., 2008). Immunoprecipitated proteins were
analyzed using Western blots with both mouse monoclonal anti-FLAG M2 (Sigma,
Cat# F1804) and Rabbit anti-GFP (Invitrogen, Cat#A11122) antibodies. For loading
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controls, we used mouse anti-alpha-tubulin (Sigma, Cat#T9026) and anti-CGH-1 (gift
of David Greenstein).

RNA quantification
To measure mett-10:gfp transgene expression relative to endogenous, each
mett-10::gfp transgene was crossed into the mett-10(ok2204) background, which
contains a large deletion of the mett-10 5’ region. Total RNA was isolated using
Trizol (Invitrogen), treated with DNase I (Epicentre), chloroform extracted, ethanol
precipitated and dissolved in water. cDNA was synthesized using random hexamer
primers and SuperScript VILO reverse transcriptase (Invitrogen). Transcripts were
quantified using Sybr green real-time PCR (Clontech) and gene-specific primers (see
below) calibrated with genomic DNA. RNA levels were calculated adjusting for
amplification efficiency (Pfaffl, 2001) and normalizing to internal cgh-1 or act-3
transcripts and external genomic DNA standards. Standard deviations were calculated
using all PCR replicates from all biological replicates.
Primers used for quantitative RT-PCR:
Gene

Forward Primer

Reverse Primer

mett-10 TGATATTGGCACCGGAACATCGTG

CATCTCCGTCAGTGGCAATGAACT

dlc-1

TGGCATTGCATCGTCGGAAGAAAC

AGACTTGAATAGCAGGATGGCGAC

act-3

TCTTGACTTGGCTGGACGTGATCT

TGATGTCACGGACGATTTCACGCT

cgh-1

ATCAACTTCCTCCCAAAGGAGCG

TCATACGGCTTGTGCATGTGCTTC
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Table 1: An RNAi screen of METT-10 yeast two-hybrid interactors reveals
multiple inhibitors of proliferative fate
%Tum
%Tum
two(rrf-1(pk1417);
GFP(RNAi)
tailed
gene name
COSMID
glp-1(oz264) (n)
control (n)
p-value

dlc-1

R07B7.2
T26A5.9

16.9(130)
87.5(88)

14.6(96)
11.8(76)

0.71
<0.0001*

pqn-59
plk-1
#
vab-3
#
eya-1

R119.4
C14B9.4
F14F3.1
C49A1.4

58.8(216)
22.5(80)
7.9(68)
18.8(154)

14.9(262)
26.9 (26)
13.8(50)
12.3(138)

<0.0001*
0.79
0.26
0.15

npp-9
mpk-1
pmk-1
ran-1

F59A2.1
F43C1.2
B0218.3
W03D8.3
K01G5.4

16.7(66)
0(70)
12.8 (86)
6.8(88)
6.9(58)

10.0 (70)
18(50)
11.8 (76)
9.6 (94)
20.8(96)

0.31
0.0002**
1
0.59
0.02**

hrd-1
scrm-8
cks-1
tag-332

F55A11.3
K08D10.7
C09G4.3
Y119C1B.8

51.6(192)
9.7(72)
25.0 (144)
62.5(152)

16.7(192)
9.6(94)
13.1(130)
12.3(154)

<0.0001*
1
0.006*
<0.0001*

All genes are organized by "interactome" branch, with the first row after each division
occupied by the gene predicted to be a primary interactor of METT-10.
#
vab-3 and eya-1 are found in two separate interactome branches, and are predicted to
directly interact with both pqn-59 and npp-9.
*RNAi treatments that led to significant enhancement of the glp-1(oz264) tumorous
phenotype.
**RNAi treatments that significantly suppressed glp-1(oz264) overproliferation. All animals
were scored at 2 days past the L4 stage at 20˚C. p-values were calculated by Fisher's exact
test, using simultaneous GFP RNAi treatments to calculate expected values.
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Table 2 : transgenic rescue of mett-10 phenotypes
mett-10(ok2204) @ 25˚C

A.
transgene
% Pvl
% Ste
no transgene
98
99
met-10(wt)::gfp
5
0
**
mett-10(5A)::gfp LOW
65
19
mett-10(5A)::gfp HIGH
1
0
mett-10 (enzymaticdefective,5A)::gfp, line 1
92
98
mett-10 (enzymaticdefective,5A)::gfp, line 2
97
99
mett-10(-NLS,5A)::gfp line 1
0
19
mett-10(-NLS,5A)::gfp line 2
0
14
*gonads with one or more ectopic distal protrusions.
**two-tailed p-value, Fisher's exact test < .05
Pvl = protruding vulva, Ste = sterile

B.

transgene
no transgene
met-10(wt)::gfp
mett-10(5A)::gfp LOW
mett-10(5A)::gfp HIGH
mett-10 (enzymaticdefective,5A)::gfp, line 1
mett-10 (enzymaticdefective,5A)::gfp, line 2
mett-10(-NLS, 5A)::gfp, line 1
mett-10(oz36)::gfp
mett-10(oz36:SV40NLS)::gfp

n
82
38
43
137

% abnormal gonad
shape (n)*
30(44)
0(35)
n.d.
3(32)**

46

30(43)

97
42
36

n.d.
10(31)**
12(25)

% Tumorous germ lines (n)
mett10(ok2204)
(m-z-, 15˚C)

glp-1(oz264)
mett-10(g38)
(m+z-)

0(96)
0(136)
0(86)
0(36)

mett-10(oz36)
(m+z-, 20˚C)
41(66)
0(80)
0(86)
n.d.

0(36)

n.d.

91(84)

0(48)
0(37)
n.d.
n.d.

2(107)
0 (128)
94(90)
97(74)

94(83)
4.3 (94)
n.d.
n.d.
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89(47)
0(56)
0(54)
n.d.

Table 3: compromising dynein function enhances the
tumorous phenotype of the mett-10(oz36) mutant
genotype
%Tum
n
#
A. dlc-1
rrf-1(pk1417); mett-10(oz36); gfp(RNAi)
3
117
rrf-1(pk1417); dlc-1(RNAi)
0
122
rrf-1(pk1417); mett-10(oz36); dlc-1(RNAi)
62
130
$

B. dynein heavy chain
dhc-1(or195)
mett-10(oz36)
dhc-1(or195); glp-1(oz264)
dhc-1(or195); mett-10(tm2697)
dhc-1(or195); mett-10(g38)
dhc-1(or195); mett-10(oj32)
dhc-1(or195); mett-10(ok2204)
dhc-1(or195); mett-10(oz36)
dhc-1(or195); glp-1(bn18) mett-10(oz36)
dhc-1(js319)
dhc-1(js319); glp-1(oz264)
dhc-1(js319); mett-10(tm2697)
dhc-1(js319); mett-10(g38)
dhc-1(js319); mett-10(oj32)
dhc-1(js319); mett-10(ok2204)
dhc-1(js319); mett-10(oz36)
dhc-1(js319); glp-1(bn18) mett-10(oz36)
dhc-1(js121); mett-10(oz36)

0
43
9
0
0
0
0
100**
0
0
6
0
0
0
0
76**
0
3

37
65
22
35
18
26
65
46
38
26
17
59
40
30
24
42
52
35

#

Animals were m-z-, i.e. came from homozygous mutant
mothers. The rrf-1(pk1417) enables germ line restricted RNAi.
All RNAi and scoring was carried out at 20˚C.
$

All animals were m+, i.e. came from mothers carrying a wild
type copy of mett-10 and were scored at 2 days past L4 at 20˚C
by dissection and DAPI staining.

** indicates significance calculated by Fisher's exact test, using
mett-10(oz36) alone for expected values.
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Table 4: mett-10 loss-of-function alleles enhance mitotic and meiotic defects
of a dhc-1 allele.
% Germ lines
with polyploid
with univalents
genotype
n
nuclei
in diakinesis
dhc-1(js319)
4
4
26
dhc-1(js319); glp-1(oz264)
5
0
19
dhc-1(js319); mett-10(tm2697)
100
42
59
dhc-1(js319); mett-10(g38)
100
30
40
dhc-1(js319); mett-10(ok2204)
92
8
24
dhc-1(js319); mett-10(oj32)
97
3
30
dhc-1(js319); mett-10(oz36)
100
42
dhc-1(js319); glp-1(bn18) mett-10(oz36)
100
12
52
Polyploid nuclei are large and DAPI dense. These are distinct from the enlarged,
diffusely staining nuclei indicative of cell cycle arrest observed in mett-10(-) mutants.
All animals were m+, i.e. came from mothers carrying a wild type copy of mett-10 and
were scored at 2 days past L4.
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Figure 1. Organization of the C. elegans germ line. (A) A fluorescence micrograph
of a dissected, DAPI-stained adult C. elegans hermaphrodite germ line with
schematic. In the distal region proliferating germ cells (2) reside in close contact with
the somatic distal tip cell (1). At the transition zone (3), germ cells enter meiosis, and
proceed through meiotic prophase (4) to give rise to sperm (6) and oocytes (5). (B)
Scheme depicting the decision that C. elegans germ line stem cells have to make
between maintaining a proliferative fate (green) versus differentiation (red), to
produce gametes.
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Figure 2. Schematic of yeast two-hybrid interactome for METT-10. Each
individual line indicates a direct interaction identified in a genome-wide yeast twohybrid screen (Li et al., 2004). Ovals represent an individual gene. Shaded ovals
represent genes whose disruption by either mutation RNAi enhances glp-1(oz264gf)
overproliferation.
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Figure 3. dlc-1 inhibits proliferative fate in the C. elegans germ line. (A) RNAi
against dlc-1 and dhc-1 enhances tumor formation in the glp-1(oz264gf) background
at 20˚C, while RNAi against other light chains does not; dlc-2: paralog of dlc-1; dylt1: Tctex-type dynein light chain; dyrb-1: Roadblock-type light chain. Two-tailed pvalues determined using Fisher’s Exact Test. In wild type germ lines (B) as well as in
dlc-1 RNAi of control animals (C), a 3 hr pulse of the nucleotide analog EdU, which
incorporates during DNA synthesis, labels (green) only the very distal end (left) of
the germ line, although dlc-1 RNAi causes polyploid nuclei containing large, dense
DNA bodies (white arrow) and unpaired chromosomes in diakinesis. Insets show
chromosomal morphology of diakinetic oocytes, with 6 sets of bivalents in oocytes
from control germ lines (B), but 12 univalents for dlc-1 RNAi (C). (D-E) dlc-1 RNAi
causes tumor formation and EdU incorporation throughout the germ line in glp1(oz264gf) (E), while glp-1(oz264gf) mutant on its own has only a marginal increase
in EdU-incorporation (D). (F-H) Staining against DLC-1 in glp-1(oz264gf) animals
treated with dsRNA targeting either gfp as a control (F) or dlc-1 (G-H). (G) a
tumorous germ line with partial DLC-1 knockdown and unaffected nuclear
morphology and (H) a tumorous germ line with strong DLC-1 knockdown and
abnormal nuclear morphology. (I) Inset from (H) highlights the large size of
abnormal nuclei. Solid arrows indicate large, DNA dense (abnormal) nuclei, and
feather arrows indicate nuclei of relatively normal size. (J) Quantification of DLC-1
levels by pixel intensity for glp-1(oz264gf); gfp(RNAi) germ lines (white bar), glp1(oz264gf);dlc-1(RNAi) tumorous germ lines with normal nuclear morphology (black
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bar), and glp-1(oz264gf);dlc-1(RNAi) tumorous germ lines with abnormal nuclear
morphology (grey bar). Error bars indicate the SEM. All scale bars = 20 microns.
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Figure 4. DLC-1 promotes METT-10 nuclear accumulation. (A) METT-10::GFP
expression in a wild type germ line. (B) dlc-1 RNAi causes a decrease in METT10::GFP accumulation, abnormal nuclear morphology (left panel), and unpaired
chromosomes in diakinesis (right panel, yellow arrows). (C) METT-10::GFP nuclear
accumulation is delayed in the dhc-1(or195) mutant background, with nuclear
accumulation observed only in late pachytene. Solid and feather arrows indicate
nuclei positive and negative for METT-10::GFP, respectively (D) IP-westerns for
METT-10:GFP levels in whole animals subject to both control (empty vector) RNAi
as well as dlc-1(RNAi). CGH-1 is a germ line ubiquitous protein. (E) qRT-PCR for
dlc-1 and mett-10 normalized to cgh-1 mRNA levels. RNAi was carried out in the
rrf-1(pk1417) background, which retains RNAi only in the germ line. (F) METT10(5A)::GFP protein is reduced in germ line nuclei, although some nuclear METT-10
(5A):GFP is observed in nuclei of the somatic gonad (see circled sheath cell nucleus).
At variable penetrance, abnormal, DNA-dense nuclei similar to those observed for
dlc-1 (RNAi) are seen at the distal end. Germ line shown is more severe than most.
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Figure 5. METT-10 binds DLC-1 in vitro. (A) Full length 6X-HIS METT-10 is
pulled down by GST-DLC-1, weakly pulled down by GST-DLC-2, and not by GSTDYLT-1 or GST-DYRB-1. (B) GST-DLC-1 point mutants (Coomassie) were assayed
for binding to full length 6XHIS-METT-10 proteins. (C) A dimeric band (feathered
arrow) is observed when full length 6X-HIS-METT-10 is pulled down with GSTDLC-1 and full length GST-METT-10. (D) Fine mapping of the DLC-1 binding
domain of METT-10 using GST-pulldown analysis analogous to that shown in (A).
The identity of individually-mutated METT-10 residues are labeled on the left.
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Figure 6. METT-10 can form multimers. (A) Western blot analysis on bacterially
expressed 6XHIS-METT-10 fusion proteins reveals bands that run at the size of
monomers (*) and dimers ($). (B) GST pulldown analysis between METT-10 protein
fragments. The C-terminal METT-10 protein fragment (aa 272-479) binds full length
and METT-10(oz36) (aa 1-271) protein fragments (gel on left). Feathered arrow
indicates that 6XHIS-METT-10(C-term) runs at the size of a dimer. 6XHIS-METT10(oz36) protein fragment can bind a GST-tagged METT-10(oz36) fragment, but no
dimeric band is observed (gel on right).
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Figure 7. METT-10 and DLC-1 do not co-localize in vivo. Scanning-Laser
Confocal images of germ cells in meiotic pachytene co-stained with an antibodies
against METT-10::GFP (green) DLC-1 (red), and DAPI to visualize DNA (blue). (A)
DLC-1 is a predominantly cytoplasmic protein, although some nuclear puncta are
observed, agreeing with previous findings in mammalian cells (Rayala et al., 2005).
(B) METT-10::GFP is predominantly nucleocytoplasmic in pachytene germ cells,
although there appears to be some punctate staining within the nucleus as well. (C)
Merge of (A) and (B). METT-10::GFP and DLC-1 do not colocalize; rather, nuclear
puncta appear to be adjacent to one another. (D) Neither DLC-1 nor METT-10::GFP
puncta extensively co-localize with DNA.
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Figure 8. A dual mechanism ensures METT-10 nuclear accumulation. (A)
Domain architecture of METT-10 marked with protein sequence change caused by
mett-10(oz36) and location of the DLC-1 binding motif. Gray shading highlights the
conserved methyltransferase-10 domain, and purple indicates the nuclear localization
consensus sequence. (B-G) Confocal images (0.3 microns) of wild type and mutant
METT-10::GFP expression in gonadal sheath cells stained with antibodies against
GFP and lamin to visualize nuclear membrane.
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Figure 9. Measurements of mett-10 transgenic and endogenous expression. (A)
qRT-PCR analysis for levels of endogenous and transgenic mett-10 expression. All
transgenes were crossed into the mett-10(ok2204) background, which contains a large
deletion of the N-terminal portion of the gene. Primers corresponding to this deleted
region were used to measure gene expression (see Methods). These primers amplify
the endogenous gene in a wild type genetic background, and only the transgene in the
mett-10(ok2204); mett-10::gfp genetic background. Expression values shown
correspond to a calculated ratio of mett-10 to actin expression, with endogenous gene
expression normalized to a value of 1 (see Methods). (B) IP-Westerns of wild type
and mett-10(5A)::gfp transgenes.
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Figure 10. A cytoplasmic version of METT-10 can partially suppress the mett10(ok2204) RNAi-resistance phenotype. mett-10(ok2204) animals carrying either
wild type mett-10::gfp, mett-10(5A)::gfp, or mett-10(-NLS, 5A)::gfp were fed dsRNA
directed against the germ line –expressed gene, gld-1. F1 animals were scored for
two phenotypes associated with gld-1 disruption: small oocytes (less severe) and
ectopic proximal proliferation (more severe).
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Figure 11. mett-10 mutants enhance dynein loss-of-function phenotypes of the
dhc-1(js319) allele. (A, C-D) Most dhc-1(js319)mutant germ lines are relatively
normal at both 20 and 25˚C, although they exhibit polyploidy (large DNA-dense
nuclei) and univalent (unpaired chromosomes in diakinesis) at very low penetrance.
(B, E-F) Double mutants between dhc-1(js319) and any mett-10 allele leads to
significant enhancement of both these phenotypes, and all double mutant animals are
sterile. This set of phenotypes closely phenocopies loss of dlc-1 function in the germ
line.
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Figure 12. Schematic of dynein heavy chain-1 mutations. (A) Diagram of
intron/exon structure of the dhc-1 locus, with encoded protein domains. The Nterminal tail region contains that binding sites for Dynein Intermediate Chain (DIC)
and Dynein Light Intermediate Chain (LIC) (blue) (Tynan et al., 2000). These are
followed by the first four ATPase domains containing consensus P-loop sequences
(yellow), followed by the microtubule stalk and globular microtubule binding domain
(red) (Koonce and Tikhonenko, 2000). Locations of the nucleotide changes in dhc1(js121), dhc-1(or195), and dhc-1(js319) are shown. (B) Model of Dynein Heavy
Chain with location of mutant alleles. If we assume that the splice acceptor mutations
lead to exon skipping, dhc-1(js121) would lead to a deletion within the linker domain,
while dhc-1(js319) would truncate DHC-1 C-terminal to the 5th and 6th ATPase-like
domains.
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Chapter 4 (Discussion):
The Pleiotropic Consequences of mett-10 Disruption
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“Always the beautiful answer who asks a more beautiful question.”
-e.e. cummings, 1938
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The goal of development is to build and maintain an organism. METT-10 is
an interesting protein in that it plays roles in both the construction and maintenance of
C.elegans. In addition to an essential role in development of the embryo, vulva, and
somatic gonad, METT-10 regulates germ cell proliferation and promotes the
production of gametes by ensuring normal mitotic cell cycle progression and meiotic
development. These essential functions of METT-10 in germ cells maintain the
gamete population in adult life and the species in general.
Although our initial interest in mett-10 centered on its function in proliferative
fate specification, the studies presented here uncovered additional cellular roles in
RNA interference, dynein function in mitosis and meiosis, cell cycle progression, and
meiotic development. A central question that arises from these findings is whether a
single cellular function underlies the diversity of mett-10 phenotypes and whether
some phenotypes are the downstream consequences of another. Alternatively, these
cellular functions and their associated phenotypes might be separable and
independent. Understanding the causal relationship between underlying cellular
function and phenotype will enhance our understanding of the construction and
maintenance of the organism as a functioning whole, and the imbalance that underlies
disease.

Methyltransferase activity likely underlies all cellular functions of METT-10
METT-10 most likely functions as a methyltransferase. It contains a full
SAM-dependent methyltransferase fold and the human homolog binds SAM (Wu et

153

al., To be published.). Significantly, the oj32 allele mutates a highly conserved
glycine that forms the core of the SAM-binding pocket, and is predicted to reduce
methyltransferase activity. The mett-10(oj32) mutant exhibits defects in proliferative
fate specification, RNA interference, cell cycle progression, and promotion of dynein
function, suggesting that methyltransferase activity underlies all METT-10 cellular
functions (Figure 1). We do not know what METT-10 methylates, or the functional
consequence of methylation, but it is likely that METT-10 has multiple targets. This
is supported by the phenotype of the tumorous mett-10(oz36) mutant, which
preferentially affects proliferative fate specification under lower temperature
conditions.

Joint functions of METT-10 and dynein in the C. elegans germ line
DLC-1 and METT-10 cooperatively inhibit proliferative cell fate (Figure 1).
DLC-1 interacts physically with METT-10, promotes mett-10 RNA levels, and, in the
context of the motor complex, promotes METT-10 nuclear localization. Moreover,
the role of dynein in regulation of proliferative fate is not limited to regulation of
METT-10 alone, as genetic disruption of either dlc-1 or dhc-1 can enhance the
tumorous phenotype of the mett-10(oz36) mutant that lacks the DLC-1-binding motif.
In addition to a joint function in proliferative fate specification, METT-10
promotes other dynein-dependent processes (Figure 1). Loss of mett-10 function
enhances the mitotic and meiotic defects of a weak dynein heavy chain loss-offunction allele, leading to polyploidy and unpaired diakinetic chromosomes.
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Expression of a METT-10 protein that is unable to bind DLC-1 acts as a dominant
negative and causes germ cell polyploidy, suggesting that it may disrupt a DLC-1containing complex. Finally, the mett-10(oj32) loss-of-function allele has a defect in
centrosome flattening, a dynein-dependent process, during the first embryonic
division (O'Connell et al., 1998).
The genetic interactions between mett-10 and dlc-1 in proliferative fate
specification, mitotic cell division, and meiosis suggest that these different cellular
functions may have a common underlying mechanism. However, the experiments
presented here delineate a role for DLC-1 in promoting METT-10 activity during
proliferative fate specification, and a role for METT-10 in promoting DLC-1 activity
during cell division and meiotic pairing and/or recombination. The most
parsimonious interpretation of these findings is that METT-10 promotes DLC-1
activity, which, in turn, promotes METT-10 function in a positive feedback loop
(Figure 2).
How could METT-10 affect DLC-1 function? DLC-1 is an LC8-type dynein
light chain, which exists as a dimer when associated with the dynein motor complex
(Vale, 2003). Two models have been proposed for the role of the LC8 dynein light
chain with respect to the dynein motor complex. One model suggests that LC8 dimers
act as dimerization hubs, binding to regions of intrinsic disorder in a diverse set of
proteins, leading to increased structural organization and dimerization (Wang et al.,
2004; Barbar, 2008). This model proposes that LC8 promotes normal dynein function
by promoting dimerization of the dynein intermediate chain (Barbar, 2008; King,
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2008). Indeed, since METT-10 can simultaneously bind to itself and to DLC-1, it is
possible that DLC-1 promotes METT-10 dimerization in vivo. A second model
proposes that DLC-1/LC8 functions as a cargo adaptor molecule, enabling the
association of the dynein motor complex with a wide spectrum of proteins (Karki and
Holzbaur, 1999; Navarro et al., 2004; Lee et al., 2006). The unifying theme of both
models is that DLC-1 carries out multiple cellular functions by binding to and
regulating the function of a diverse set of target proteins. It is possible that METT-10
methylates targets of the dynein motor complex, and that this methylation event
promotes their association with DLC-1 or the motor complex. Alternatively, METT10 and DLC-1 could coordinately regulate target proteins by coupling multiple modes
of regulation, such as post-translational modification and subcellular localization. In
both cases, association with dynein would enhance METT-10 function, but may not
be essential.

The relationship of RNA interference to other METT-10 cellular functions
Small RNAs play broad roles in development, and given their roles in
regulation of gene expression and chromatin structure, it is no surprise that defects in
RNA-mediated silencing lead to widespread alterations in development (Zamore and
Haley, 2005) . Indeed, the microRNA pathway was first characterized for its role in
developmental timing, and many RNAi genes, particularly the Argonaute family of
proteins, play essential and conserved roles in germ line maintenance and function
(Lee et al., 1993; Deng and Lin, 2002; Yigit et al., 2006). Moreover, multiple RNAi
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mutants exhibit cell division defects that are thought to arise from function of RNAmediated silencing in regulation of chromatin structure (Zamore and Haley, 2005;
Yigit et al., 2006). Thus, while the role of METT-10 in RNAi is unlikely to
completely account for its function in proliferative fate specification (see Discussion,
Chapter 2), it probably contributes to the gross morphological defects observed in
mett-10 mutants (Figure 1).
Could there be any functional overlap between the roles of METT-10 in RNAi
and in dynein function? While we did not detect an RNAi defect for multiple alleles
of dynein heavy chain-1 (data not shown), several emerging lines of evidence point to
a functional connection between RNAi-related processes and the cytoskeleton. In
Drosophila germ cells, defects in the piRNA pathway lead to the formation of large
aggregates of dynein heavy chain in the cytoplasm (Navarro et al., 2009). Moreover,
two different RNAi screens have identified roles for cytoskeletal factors in promoting
RNA-mediated silencing pathways. For example, a group of genes that act in the
dynein–dependent pathway mediating asymmetric division and centrosome flattening
(lin-5 and gpr-1/2) can promote transgene silencing (Kim et al., 2005), while roles for
tubulin, dynactin, and various dynein subunits are proposed to mediate lin-14
silencing via the microRNA pathway (Parry et al., 2007). Thus, it is possible that the
dual roles of METT-10 in dynein function and RNAi are not coincidental, and further
investigation may illuminate a mechanism underlying the functional connections
between the cytoskeleton and RNA-mediated silencing.
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A complete picture?
An organism is less the sum of its component parts than it is the sum of their
connections. Homeostasis and survival require not just that individual organs or
tissues are connected, but that all cellular pathways are connected to each other in a
network. Genome-wide studies of gene expression and physical association of
proteins can drive our ideas of how such vast networks are organized, but in depth
studies of genes like mett-10 whose roles span seemingly disparate cellular functions
may eventually make concrete contributions to our understanding of the complex
interactions between cellular machinery, gene regulatory mechanisms, and the
phenotypic consequences of their disruption.
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Figure 1. A model for the pleiotropic consequences of mett-10 disruption.
METT-10 plays roles in multiple cellular processes, but the relationship between
these processes (yellow), their underlying mechanisms (orange), and the phenotypic
consequences of their disruption (green) are not well understood. It is likely that
METT-10 methyltransferase activity (red) is essential for all METT-10 functions, that
METT-10 has multiple targets, that there is significant interplay between these
functions, and that the phenotypic effects of mett-10 disruption are the downstream
consequence of multiple underlying cellular defects. In the diagram, line thickness
represents strength of experimental evidence supporting the functional connection,
with dotted lines have the least supporting experimental evidence.
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Figure 2. A genetic model for joint functions of METT-10 and DLC-1. METT10 and DLC-1 both function in glp-1-dependent inhibition of proliferative fate, the
avoidance of polyploidy, centrosome flattening (O'Connell et al., 1998), and in
meiotic pairing and/or recombination. In the inhibition of proliferative fate, DLC-1
promotes METT-10 levels and localization. However, dlc-1 activity is essential for
other functions (red), while METT-10 function is not. The most parsimonious
explanation is that METT-10 normally promotes DLC-1 function, and DLC-1 in turn
promotes METT-10 activity in a positive feedback loop.
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